[
    {
        "src_smiles": "Cn1c(SCC(=O)Nc2ccccc2)nc2ccccc2c1=O",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Cn1c(SCC(=O)Nc2ccccc2)nc2ccccc2c1=O, features a central N-methylated benzimidazolone core. This core is connected via a methylthio (-S-CH2-) linker to an acetamide group (-C(=O)NH-). The acetamide nitrogen is substituted with a terminal phenyl ring.\",\n    \"Property_Analysis\": \"The benzimidazolone scaffold is a known hinge-binding motif in various kinase inhibitors. The acetamide linker positions the terminal phenyl group towards the solvent-exposed region or potentially interacts with specific pockets within the ATP-binding site of JNK3. The overall structure suggests potential interaction with the JNK3 active site, but potency and selectivity depend heavily on the specific interactions formed by the terminal phenyl group and the linker orientation.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted terminal phenyl ring might lack specific interactions (e.g., hydrogen bonds, strong hydrophobic interactions) required for high-affinity binding to JNK3. Its flexibility, combined with the thioacetamide linker, might lead to suboptimal positioning or entropic penalties upon binding. The thioether linkage could also be susceptible to metabolic oxidation.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, modifications focus on the terminal phenyl group to enhance interactions within the relevant subpocket of the ATP binding site. Introducing substituents on the phenyl ring can modulate electronic properties and probe for additional hydrogen bonding or hydrophobic interactions. Replacing the phenyl ring with a substituted heterocycle is another common strategy. For this optimization, a chlorine atom will be added to the meta-position of the terminal phenyl ring to explore potential hydrophobic interactions or favorable contacts within the JNK3 active site, a common modification in kinase inhibitor design.\",\n    \"Final_Target_Molecule\": \"Cn1c(SCC(=O)Nc2ccc(Cl)cc2)nc2ccccc2c1=O\"\n  }\n]"
    },
    {
        "src_smiles": "NC(=O)c1cncnc1Nc1cccc(C(F)(F)F)c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features an aminopyrazine carboxamide core linked via a secondary amine to a meta-trifluoromethylphenyl ring. Key functional groups include the pyrazine nitrogens (H-bond acceptors), carboxamide (H-bond donor/acceptor), secondary amine (H-bond donor), and the lipophilic, electron-withdrawing trifluoromethyl group.\",\n    \"Property_Analysis\": \"JNK3 inhibition often involves interactions with the ATP binding site. The aminopyrazine core can potentially interact with the kinase hinge region via hydrogen bonds. The carboxamide group can form additional hydrogen bonds, and the trifluoromethylphenyl group likely occupies a hydrophobic pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The position of the carboxamide on the pyrazine ring and the meta-trifluoromethyl substitution on the phenyl ring may not be optimal for maximizing interactions within the JNK3 active site. The overall combination might lack specific interactions needed for high potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Maintain the aminopyrazine-NH-phenyl core structure for hinge binding. Remove the potentially suboptimal carboxamide from the pyrazine ring. Replace the meta-CF3 group with a substituent known to enhance JNK3 inhibition, such as a meta-sulfonamide group on the phenyl ring, which can form favourable interactions in the pocket.\",\n    \"Final_Target_Molecule\": \"NS(=O)(=O)c1cccc(Nc2cncnc2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ncc2nc(-c3ccc(F)cc3)c(=O)n(C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, SMILES: COc1ncc2nc(-c3ccc(F)cc3)c(=O)n(C)c2n1, features an imidazo[1,2-a]pyrazin-8(7H)-one core. Key substituents include a methoxy group (-OMe) on the pyrazine ring, an N-methyl group (-CH3) on the imidazole ring nitrogen, and a 4-fluorophenyl group attached to the imidazole ring.\",\n    \"Property_Analysis\": \"The target property is the inhibition of c-Jun N-terminal kinase 3 (JNK3). The source molecule is assumed to possess some level of JNK3 inhibitory activity, serving as a starting point for optimization.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methoxy group at position 6 might not be optimal for hydrogen bonding interactions within the JNK3 active site's hinge region, potentially limiting potency. Additionally, its metabolic stability could be a concern (O-demethylation). The N-methyl group might influence solubility or specific interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance binding affinity through improved hydrogen bonding interactions with the JNK3 hinge region, the methoxy group (-OMe) at position 6 is replaced with a hydroxyl group (-OH). This modification introduces a hydrogen bond donor functionality.\",\n    \"Final_Target_Molecule\": \"Oc1ncc2nc(-c3ccc(F)cc3)c(=O)n(C)c2n1\"\n  }\n]"
    },
    {
        "src_smiles": "c1cc(Nc2ccon2)nc(Nc2ccc(N3CCOCC3)cc2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central pyrimidine core with diamino substitutions at positions 2 and 4. Position 2 is substituted with an oxazol-2-ylamino group. Position 4 is substituted with a 4-(morpholin-4-yl)phenylamino group.\",\n    \"Property_Analysis\": \"The diaminopyrimidine scaffold is a common hinge-binding motif in kinase inhibitors. The aniline linker connects to the morpholine-substituted phenyl ring, likely interacting within the ATP binding site and potentially extending towards the solvent-exposed region. The oxazole group is a relatively small heterocycle contributing to the overall binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The oxazole ring at position 2 might offer suboptimal interactions (e.g., hydrogen bonding, hydrophobic interactions) within the JNK3 binding pocket compared to other heterocycles. Its specific electronic and steric properties might limit the overall potency or selectivity for JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the oxazole ring with a thiazole ring. Thiazole rings are isosteric replacements often used in kinase inhibitors. The sulfur atom in thiazole offers different electronic properties and potential interactions compared to the oxygen in oxazole, which might lead to improved binding affinity or better fit within the specific JNK3 active site.\",\n    \"Final_Target_Molecule\": \"c1cc(Nc2sccn2)nc(Nc2ccc(N3CCOCC3)cc2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1ccc(-c2csc3ncnc(NCCCC(=O)O)c23)cc1C",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a thieno[2,3-d]pyrimidine core. A 4,4'-dimethylphenyl group is attached at position 2 of the thiophene ring. An N-(4-carboxybutyl)amino side chain (-NCCCC(=O)O) is attached at position 4 of the pyrimidine ring.\",\n    \"Property_Analysis\": \"The thieno[2,3-d]pyrimidine scaffold likely acts as a hinge binder, common for kinase inhibitors. The N-alkylamino side chain extends towards the solvent-exposed region, with the terminal carboxylic acid potentially forming polar interactions or salt bridges. The dimethylphenyl group occupies a hydrophobic pocket near the ATP binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The flexible N-(4-carboxybutyl)amino side chain might adopt conformations unfavorable for strong binding, leading to an entropic penalty. The terminal carboxylic acid could negatively impact cell permeability and metabolic stability despite potential binding benefits. The dimethylphenyl group might not be optimal for filling the hydrophobic pocket for JNK3 specifically, potentially limiting potency and/or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially selectivity, introduce rigidity into the N4 side chain while retaining a polar/acidic group for interaction. Replacing the flexible butyl chain with a piperidine ring linked via its nitrogen atom, carrying the carboxylic acid group at position 4, could achieve this. This modification constrains the conformation and positions the carboxylic acid in a defined vector, potentially enhancing interactions within the target site.\",\n    \"Final_Target_Molecule\": \"Cc1ccc(-c2csc3ncnc(N4CCC(C(=O)O)CC4)c23)cc1C\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(Nc1cnccn1)c1ccccc1NCc1ccncc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule is N-(pyrazin-2-yl)-4-(pyridin-4-ylmethyl)benzamide. It consists of a central benzamide core. The amide nitrogen is attached to a pyrazine ring (pyrazin-2-yl). The carbonyl carbon is attached to a benzene ring, which is further substituted at the para position with a methylene linker (-CH2-) connected to a pyridine ring (pyridin-4-yl).\",\n    \"Property_Analysis\": \"JNK3 inhibitors typically interact with the ATP binding site. Key interactions often involve hydrogen bonding with the hinge region (e.g., Met111 backbone NH) and occupation of hydrophobic pockets. The amide NH group and potentially nitrogen atoms in the pyrazine ring could act as hydrogen bond donors/acceptors for hinge binding. The aromatic rings (benzene, pyridine) are expected to occupy hydrophobic pockets within the active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The pyrazine ring may not be the optimal heterocycle for strong hinge binding compared to motifs like aminopyrimidines or indazoles found in known potent JNK3 inhibitors. The overall shape and electronic properties defined by the specific combination of pyrazine, benzamide, and pyridinylmethyl groups might lead to suboptimal complementarity with the JNK3 active site, potentially limiting potency and/or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve hinge binding, the pyrazin-2-amine moiety is replaced with pyrimidin-4-amine, a common and effective hinge-binding group in kinase inhibitors. Additionally, a fluorine atom is introduced ortho to the amide linkage on the central benzene ring. This modification can influence conformation, potentially improve metabolic stability, and may introduce favorable interactions within the active site.\",\n    \"Final_Target_Molecule\": \"O=C(Nc1ncncc1)c1c(F)cccc1NCc1ccncc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(-c2cccc(O)c2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule is a benzocoumarin derivative, specifically 3-(3-hydroxyphenyl)-7,8-benzocoumarin. Key features include the rigid, planar benzocoumarin core containing a lactone (ester) functional group, and a meta-substituted hydroxyphenyl group attached at the 3-position.\",\n  \"Property_Analysis\": \"Coumarin derivatives are known scaffolds for various biological activities, including kinase inhibition. The benzocoumarin core likely provides hydrophobic interactions within the ATP binding site of JNK3. The 3-hydroxyphenyl substituent can potentially form hydrogen bonds with residues in the active site. The overall planarity might facilitate pi-stacking interactions.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The meta-position of the hydroxyl group on the phenyl ring might not be optimal for forming strong hydrogen bonds with the key hinge region residues of JNK3, which often favor para-substituted phenols or related bioisosteres. The overall potency might be limited due to suboptimal interactions or unfavorable physicochemical properties.\",\n  \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the interaction with the hinge region can be optimized. Relocating the hydroxyl group from the meta to the para position on the phenyl ring could facilitate stronger hydrogen bonding. Additionally, introducing a hydrogen bond donor/acceptor group, such as an amino group, ortho to the para-hydroxyl group might further enhance binding affinity by forming additional interactions with the kinase active site.\",\n  \"Final_Target_Molecule\": \"Nc1ccc(-c2cc(=O)oc3c2ccc2ccccc23)cc1O\"\n}]"
    },
    {
        "src_smiles": "Nc1ccc(C(=O)C=Cc2ccc(-c3ccccc3)cc2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Nc1ccc(C(=O)C=Cc2ccc(-c3ccccc3)cc2)cc1, is a chalcone derivative. It features an aniline group (potential H-bond donor), a central phenyl ring, an \u03b1,\u03b2-unsaturated ketone (chalcone) core, and a terminal biphenyl group (hydrophobic region).\",\n    \"Property_Analysis\": \"JNK3 inhibition often involves binding to the ATP site, utilizing hydrogen bonds with the hinge region (e.g., Met residue) and hydrophobic interactions. Chalcones are known kinase inhibitors, but their reactivity and selectivity can be issues. The aniline NH2 could potentially interact with the hinge.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The aniline group might not be an optimal hinge binder in terms of positioning or basicity. The core \u03b1,\u03b2-unsaturated ketone (chalcone) is a potential Michael acceptor, which can lead to covalent binding, off-target effects, and toxicity. The large biphenyl group's contribution to binding affinity versus potential negative impacts on solubility or ADME properties is unclear without further data.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and reduce potential liabilities: 1. Replace the aniline group with a known heterocyclic hinge-binding motif, such as 3-aminopyrazole, which offers better H-bonding geometry for the kinase hinge. 2. Replace the reactive chalcone enone linker (-C(=O)C=C-) with a more stable amide linker (-C(=O)NH-) to eliminate Michael acceptor reactivity while maintaining connection and potential H-bonding interactions.\",\n    \"Final_Target_Molecule\": \"NNC1=CC(N)=C1c1ccc(C(=O)Nc2ccc(-c3ccccc3)cc2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CCCc1ccccc1)Nc1ccc(O)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, N-(4-hydroxyphenyl)-4-phenylbutanamide (SMILES: O=C(CCCc1ccccc1)Nc1ccc(O)cc1), features an amide linker connecting a 4-phenylbutyl group to a 4-aminophenol moiety. Key features include the flexible alkyl chain (propyl), a terminal phenyl ring, the central amide group (potential H-bond donor/acceptor), and the 4-hydroxyphenyl ring (potential H-bond donor/acceptor).\",\n    \"Property_Analysis\": \"The molecule possesses features common in kinase inhibitors: hydrogen bond donors/acceptors (amide NH, amide C=O, phenol OH) and hydrophobic groups (phenyl ring, alkyl chain). These could interact with the ATP binding site of JNK3. The aminophenol might interact with the hinge region, while the phenylbutyl group could occupy a hydrophobic pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The flexibility of the propyl chain might lead to an entropic penalty upon binding, potentially reducing affinity. The specific substituents and their positions might not be optimal for forming strong interactions with key residues in the JNK3 active site, particularly the hinge region or specific hydrophobic pockets. The overall potency might be low due to suboptimal geometry or lack of specific targeted interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, we can introduce rigidity and enhance specific interactions. Replace the flexible phenylbutyl group with a more rigid moiety known to fit hydrophobic pockets, such as a 4-tert-butylphenyl group. Replace the 4-aminophenol group with a 2-aminopyridine moiety. The pyridine nitrogen is a common hinge-binding element in kinase inhibitors, potentially forming stronger hydrogen bonds with the JNK3 hinge region compared to the aminophenol. This leads to a 4-tert-butyl-N-(pyridin-2-yl)benzamide structure.\",\n    \"Final_Target_Molecule\": \"CC(C)(C)c1ccc(C(=O)Nc2ccccn2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(-c2ccccc2Cl)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a naphtho[2,1-b]furan-2(1H)-one core structure. This consists of a furanone ring fused to a naphthalene system. A 2-chlorophenyl substituent is attached at the 4-position of the furanone ring. Key features include the lactone (cyclic ester) group within the furanone ring, the extended polycyclic aromatic system, and the halogenated phenyl substituent.\",\n    \"Property_Analysis\": \"The extended aromatic system likely participates in hydrophobic interactions and potentially pi-stacking within the JNK3 ATP binding site. The carbonyl oxygen of the lactone could act as a hydrogen bond acceptor. The 2-chlorophenyl group occupies a specific pocket, with the chlorine potentially involved in hydrophobic or halogen bonding interactions. The overall shape and rigidity contribute to binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The lactone moiety lacks a hydrogen bond donor group, which is often crucial for strong interaction with the kinase hinge region, limiting potency. The lactone ester bond may also be metabolically labile, leading to poor stability. The large, flat, hydrophobic nature of the fused ring system might result in poor aqueous solubility and potentially non-specific binding or promiscuity towards other kinases. The 2-chlorophenyl group may not be optimal for interactions within its binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, replace the furanone oxygen atom with a nitrogen atom to form a lactam (naphtho[2,1-b]quinolin-2(1H)-one). This introduces an N-H group capable of acting as a hydrogen bond donor, potentially improving interaction with the JNK3 hinge region and increasing metabolic stability compared to the lactone. Additionally, modify the substituent on the phenyl ring to improve interactions. Replace the 2-chloro group with a 3-hydroxyl group (-OH) to introduce a hydrogen bond donor/acceptor capability, potentially forming favorable interactions with residues in the corresponding pocket.\",\n    \"Final_Target_Molecule\": \"O=c1cc(-c2cccc(O)c2)Nc2c1ccc1ccccc12\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(-c2ccccc2)nc2cncnc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Cn1c(=O)c(-c2ccccc2)nc2cncnc21, features a pyrazino[1,2-a]pyrimidin-4-one core. Key substituents include a methyl group attached to a nitrogen atom (N-methyl), a carbonyl group (part of the pyrimidinone ring), and an unsubstituted phenyl ring attached to the pyrimidinone ring.\",\n    \"Property_Analysis\": \"The fused heterocyclic core provides a relatively rigid scaffold. The phenyl group offers a significant hydrophobic interaction domain. The nitrogen atoms within the rings and the carbonyl oxygen can potentially act as hydrogen bond acceptors, which are often crucial for kinase hinge binding. The overall structure resembles scaffolds found in some kinase inhibitors.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted phenyl ring lacks specific directional interactions and might lead to lower binding affinity or selectivity for JNK3 compared to substituted analogues. It might also be susceptible to metabolic hydroxylation. The molecule lacks strong hydrogen bond donors, which could be beneficial for interacting with the JNK3 active site.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, introduce substituents onto the phenyl ring to improve interactions within the JNK3 ATP-binding site. Adding electron-withdrawing groups or groups capable of hydrogen bonding could increase potency and selectivity. For instance, adding a fluorine atom to the para-position of the phenyl ring can enhance hydrophobic interactions and potentially improve metabolic stability without significantly increasing size.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(-c2ccc(F)cc2)nc2cncnc21\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1Br",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 2,5-dimethyl-4-bromopyrrole core linked via an exocyclic double bond C=C to the 3-position of an isatin (indole-2,3-dione) moiety. Key features include the pyrrole ring, the isatin system, the connecting double bond, methyl groups, and a bromine substituent.\",\n    \"Property_Analysis\": \"Isatin derivatives and substituted pyrroles are known pharmacophores in kinase inhibition, including JNK inhibitors. The planar structure facilitated by the C=C bond likely allows interaction with the ATP binding site of kinases. Substituents on both the pyrrole and isatin rings influence potency and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bromine atom at the 4-position of the pyrrole ring might not be optimal for JNK3 binding affinity or selectivity. Halogens can influence electronic properties and steric fit, but bromine might be too large or lack specific favorable interactions compared to other substituents in the JNK3 active site. It could also present metabolic stability or toxicity issues.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the bromine atom with a fluorine atom. Fluorine is smaller than bromine, is highly electronegative, and can potentially form favorable interactions (like hydrogen bonds or dipole interactions) within the JNK3 active site. This substitution maintains the halogen characteristic but modifies size and electronic properties, potentially improving binding affinity and pharmacological profile.\",\n    \"Final_Target_Molecule\": \"Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1F\"\n  }\n]"
    },
    {
        "src_smiles": "c1nc(N2CCCCC2)c2cc[nH]c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an imidazo[1,2-a]pyrimidine core, a common scaffold in kinase inhibitors. Position 2 is substituted with a piperidine ring (N2CCCCC2). The imidazole part of the fused system contains an N-H group capable of hydrogen bonding.\",\n    \"Property_Analysis\": \"Imidazo[1,2-a]pyrimidines are known hinge-binding motifs for various kinases, including JNKs. The piperidine substituent likely occupies a hydrophobic pocket adjacent to the ATP binding site. The overall structure suggests potential for JNK3 inhibition, but potency and selectivity depend heavily on the specific interactions mediated by the piperidine and the core.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted piperidine ring offers limited specific interactions beyond basic van der Waals contacts and might not optimally fill the targeted hydrophobic pocket for high JNK3 affinity. Its flexibility could also lead to an entropic penalty upon binding. Furthermore, the simple piperidine might not provide sufficient features for achieving high selectivity over other kinases or JNK isoforms.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance potency and potentially improve properties like solubility or metabolic stability, the piperidine ring can be replaced with a related heterocycle containing additional functionality. Replacing piperidine with morpholine introduces an oxygen atom, potentially altering polarity, solubility, and hydrogen bonding capacity within the pocket, which could lead to improved binding affinity or selectivity for JNK3.\",\n    \"Final_Target_Molecule\": \"c1nc(N2CCOCC2)c2cc[nH]c2n1\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(O)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(O)nc21, is 7-(2,6-dichlorophenyl)-4-hydroxy-1-methyl-1H-pteridin-2(3H)-one. It features a pteridinone core, a N1-methyl group, a C7-(2,6-dichlorophenyl) substituent, and a C4-hydroxyl group (potentially tautomerizing with the C4-keto form).\",\n    \"Property_Analysis\": \"The pteridinone core likely interacts with the hinge region of JNK3's ATP binding site. The 2,6-dichlorophenyl group occupies a hydrophobic pocket, contributing to binding affinity. The N1-methyl group influences solubility and potentially steric interactions. The C4-hydroxyl group can act as a hydrogen bond donor/acceptor.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The C4-hydroxyl group might not provide optimal hydrogen bonding interactions with the JNK3 hinge region compared to other groups like amines commonly found in kinase inhibitors. The potency or selectivity might be suboptimal due to the specific nature of the interactions established by the hydroxyl group and the dichlorophenyl moiety.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the C4-hydroxyl group with an amino group (-NH2). Amino groups often form stronger and more geometrically favorable hydrogen bonds with the kinase hinge region backbone compared to hydroxyl groups, potentially increasing binding affinity and potency for JNK3.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "Nc1nccc(-c2ccc3ccccc3c2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Nc1nccc(-c2ccc3ccccc3c2)n1 (4-(naphthalen-2-yl)pyrimidin-2-amine), features a 2-aminopyrimidine core attached at the 4-position to a 2-naphthyl substituent. The aminopyrimidine moiety contains hydrogen bond donors and acceptors typical for hinge-binding in kinases. The naphthyl group is a large, rigid, hydrophobic system.\",\n    \"Property_Analysis\": \"The 2-aminopyrimidine core is a well-known scaffold for kinase inhibition, likely interacting with the hinge region of JNK3 through hydrogen bonds. The naphthyl group occupies a hydrophobic pocket within the ATP binding site. The overall structure suggests potential kinase inhibitory activity, possibly targeting JNK3.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large and rigid naphthyl group might not be optimal for fitting into the specific hydrophobic pocket of JNK3, potentially leading to suboptimal potency or selectivity. The unsubstituted amino group offers limited opportunities for further specific interactions or vector growth for property optimization. The overall lipophilicity might be high.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the bulky naphthyl group can be replaced with a different hydrophobic moiety that might provide a better fit and potentially additional interactions. A substituted phenyl ring is a common strategy. Replacing the 2-naphthyl group with a 4-chlorophenyl group introduces a halogen atom which can engage in halogen bonding or improve hydrophobic interactions while reducing the size compared to naphthyl, potentially improving the fit in the JNK3 binding site.\",\n    \"Final_Target_Molecule\": \"Nc1nccc(-c2ccc(Cl)cc2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)n1cnc2c(Nc3cccc(Cl)c3)ncnc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CC(C)n1cnc2c(Nc3cccc(Cl)c3)ncnc21, features an imidazo[4,5-d]pyrimidine core. An isopropyl group is attached at the N1 position of the imidazole ring, and a 3-chloroanilino group is attached at the C6 position of the pyrimidine ring.\",\n    \"Property_Analysis\": \"This molecule belongs to a class of kinase inhibitors targeting the ATP binding site. The imidazo[4,5-d]pyrimidine core acts as a hinge-binder scaffold. The 3-chloroanilino group occupies the hydrophobic pocket adjacent to the hinge region, and its substitution pattern influences potency and selectivity. The N1-isopropyl group occupies the solvent-exposed region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"While the 3-chloro substituent likely contributes to binding affinity, it might not provide optimal interactions within the JNK3 active site compared to potentially more specific or hydrogen-bonding capable groups. The overall potency or selectivity for JNK3 might be limited by the specific interactions mediated by the 3-chloroanilino moiety.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the 3-chloroanilino group can be replaced with a different substituent designed to enhance interactions within the kinase active site. Replacing it with a 4-(pyridin-4-yl)aniline group introduces a pyridine ring, which can potentially form additional interactions (e.g., hydrogen bonds or pi-stacking) with JNK3 residues, often leading to improved potency in related kinase inhibitors.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(Nc3ccc(-c4ccncn4)cc3)ncnc21\"\n  }\n]"
    },
    {
        "src_smiles": "CCC(C)Nc1ncnc2cc(OC)c(OC)cc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCC(C)Nc1ncnc2cc(OC)c(OC)cc12, features a quinazoline core substituted at the C4 position with a sec-butylamine group and at the C6 and C7 positions with methoxy groups.\",\n    \"Property_Analysis\": \"The quinazoline scaffold is a known hinge-binding motif in kinase inhibitors. The N-alkyl amine at C4 is expected to interact with the hinge region of JNK3. The dimethoxy substitution pattern on the fused benzene ring influences solubility, metabolic stability, and potentially interacts with other parts of the ATP binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The sec-butyl group at C4 provides some hydrophobic interaction but might lack optimal hydrogen bonding interactions or specific shape complementarity within the JNK3 active site compared to aromatic or heteroaromatic amines often found in potent kinase inhibitors. Its flexibility might also lead to an entropic penalty upon binding.\",\n    \"Optimization_for_Source_Molecule\": \"To improve hinge-binding interactions and potentially overall potency, the aliphatic sec-butylamine group can be replaced with a heteroaromatic amine known to form strong hydrogen bonds with the kinase hinge region. Replacing it with 3-aminopyridine introduces a nitrogen atom capable of acting as a hydrogen bond acceptor and maintains favorable aromatic interactions.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3cccnc3)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "c1ccc(Nc2ccc(Oc3nccnc3C3CCOC3)cc2)nc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a diphenylamine core (c1ccc(N)nc1 linked to c1ccc(O)cc1 via an amine bridge). The phenoxy oxygen is connected to a 2-substituted pyrazine ring (c3nccnc3). The pyrazine ring is further substituted at the 5-position with a tetrahydrofuran (THF) ring (C3CCOC3). Key components are the pyridine, aniline, ether linkage, pyrazine, and THF.\",\n    \"Property_Analysis\": \"JNK3 (c-Jun N-terminal kinase 3) is a serine/threonine kinase. Inhibitors often target the ATP-binding site. The diphenylamine scaffold is common in kinase inhibitors, acting as a hinge-binding motif. The pyrazine-THF substituent likely occupies the solvent-exposed region or a specific sub-pocket, influencing potency and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The tetrahydrofuran (THF) group, while providing some bulk and potential hydrophobic interactions, might lack optimal interactions within the JNK3 binding pocket. It lacks strong hydrogen bond donors/acceptors compared to other common heterocyclic substituents. Its specific size and conformation might not be ideal for maximizing affinity or could introduce metabolic liabilities.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the THF moiety will be replaced with a morpholine ring. Morpholine retains a similar size and cyclic ether feature but introduces a nitrogen atom which can potentially act as a hydrogen bond acceptor, potentially forming a favorable interaction with residues in the JNK3 active site. This is a common bioisosteric replacement aimed at improving binding affinity and/or pharmacokinetic properties.\",\n    \"Final_Target_Molecule\": \"c1ccc(Nc2ccc(Oc3nccnc3C3COCCN3)cc2)nc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(N2CCOCC2)oc2c(OCc3ccccc3)cccc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=c1cc(N2CCOCC2)oc2c(OCc3ccccc3)cccc12 (3-morpholino-8-(benzyloxy)chromen-4-one), features a chromen-4-one core. Key substituents include a morpholine ring attached at position 3 via its nitrogen atom and a benzyloxy group attached at position 8 via an ether linkage.\",\n    \"Property_Analysis\": \"Chromenone scaffolds are present in various kinase inhibitors. The morpholine group often enhances aqueous solubility and metabolic stability. The benzyloxy group likely occupies a hydrophobic pocket within the JNK3 active site. The overall structure suggests potential for kinase inhibition, but specific interactions determining JNK3 potency and selectivity need evaluation.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted benzyl ring in the benzyloxy group might lack specific interactions or optimal fit within the target JNK3 pocket, potentially limiting potency. The flexibility of the benzyloxy linker could lead to entropic penalties upon binding. The ether linkage might be susceptible to metabolic cleavage (O-debenzylation). The morpholine ring, while common, may not be the optimal group for interaction with the solvent-exposed region or specific residues in JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, modifications can focus on the benzyloxy group. Replacing the terminal phenyl ring with a substituted analog, such as 4-cyanophenyl, could introduce favorable polar interactions (e.g., with backbone amides or specific residues) or improve hydrophobic packing. The cyano group is an electron-withdrawing group and can act as a hydrogen bond acceptor, potentially increasing binding affinity and improving pharmacokinetic properties compared to the simple phenyl ring.\",\n    \"Final_Target_Molecule\": \"O=c1cc(N2CCOCC2)oc3c(OCc4ccc(C#N)cc4)cccc13\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(Nc2nccc(N3CCN(C)CC3)n2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, COc1ccc(Nc2nccc(N3CCN(C)CC3)n2)cc1, features a central 2-aminopyrimidine core. A 4-methoxyaniline group is attached to the C2 position of the pyrimidine via an amine linker. A 4-methylpiperazine group is attached to the C4 position of the pyrimidine.\",\n    \"Property_Analysis\": \"The 2-aminopyrimidine scaffold is a known hinge-binding motif for kinases like JNK3. The N1 and the exocyclic amine nitrogen of the aminopyrimidine typically form hydrogen bonds with the kinase hinge region. The 4-methoxyaniline group occupies the hydrophobic pocket near the ATP binding site. The N-methylpiperazine group extends towards the solvent-exposed region, potentially influencing solubility and interacting with outer residues.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 4-methoxy substituent on the aniline ring might not provide optimal hydrophobic interactions or steric fit within the JNK3 ATP binding pocket. The flexibility of the N-methylpiperazine group could lead to an entropic penalty upon binding. Overall potency and selectivity might be limited by the specific interactions formed by these substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, modifications targeting the aniline moiety are proposed. Introducing a small substituent ortho to the methoxy group (or meta to the linking amine) could improve interactions within the hydrophobic pocket by filling additional space or inducing a more favorable binding conformation. Adding a methyl group at the 3-position of the aniline ring (ortho to methoxy) is hypothesized to improve van der Waals contacts and potentially potency.\",\n    \"Final_Target_Molecule\": \"Cc1cc(Nc2nccc(N3CCN(C)CC3)n2)ccc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "Nc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Nc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1 (4-(4-Aminophenylamino)-2-(4-chlorophenyl)thiazole), features a central thiazole ring substituted at the 2-position with a 4-chlorophenyl group and at the 4-position with a 4-aminophenylamino linker. Key functional groups include the thiazole heterocycle, a secondary amine linker, a primary aniline amine, and a para-substituted chlorophenyl ring.\",\n    \"Property_Analysis\": \"This molecule belongs to a class of aminothiazoles, which are known scaffolds for kinase inhibitors, including JNKs. The aniline nitrogen and the secondary amine nitrogen can act as hydrogen bond donors/acceptors. The thiazole nitrogen and sulfur can also participate in interactions. The 4-chlorophenyl group likely occupies a hydrophobic pocket, potentially engaging in hydrophobic interactions and possibly halogen bonding via the chlorine atom. The overall structure suggests potential ATP-competitive binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary aniline group might be susceptible to metabolic N-oxidation or conjugation, potentially affecting pharmacokinetic properties. The flexibility of the secondary amine linker might lead to entropic penalties upon binding. The specific para-position of the chlorine atom on the phenyl ring might not be optimal for maximizing affinity or selectivity towards JNK3; its interaction potential within the specific JNK3 binding site needs optimization. The overall physicochemical properties (LogP, solubility) might require tuning for better ADME profiles.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition and address limitations, modifications can be explored. Focusing on the 4-chlorophenyl group, replacing the chlorine atom with other substituents could modulate binding affinity and selectivity. Replacing the para-chlorine with a fluorine atom is a common optimization strategy. Fluorine is smaller, more electronegative, can form stronger hydrogen bonds or halogen bonds in specific contexts, and often improves metabolic stability and membrane permeability compared to chlorine, while maintaining occupancy in a similar hydrophobic pocket.\",\n    \"Final_Target_Molecule\": \"Nc1ccc(Nc2nc(-c3ccc(F)cc3)cs2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3ccc(N)cc3)c2cc1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a quinazoline core substituted with two methoxy groups at positions 6 and 7. Position 4 is substituted with an aniline group via an amine linker (N-phenylquinazolin-4-amine). The aniline ring itself is further substituted with an amino group at the para position.\",\n    \"Property_Analysis\": \"The quinazoline scaffold is a known hinge-binding motif for many kinase inhibitors, including JNK inhibitors, by mimicking the adenine moiety of ATP. The N-phenyl substituent at C4 typically extends towards the gatekeeper residue and solvent-exposed region. The 6,7-dimethoxy groups likely occupy the ribose pocket. The para-amino group on the phenyl ring offers a point for potential hydrogen bonding or further modification.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The current para-amino group on the aniline ring might not provide optimal interactions (e.g., potency, selectivity) within the JNK3 active site compared to more tailored substituents. It could also be susceptible to metabolic N-oxidation or conjugation, potentially affecting pharmacokinetic properties. More complex substituents are often required to achieve high potency and selectivity for JNK3 by forming specific interactions in the binding pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the para-amino group on the aniline ring will be replaced. A morpholinomethyl group is introduced at this position. Morpholine is often used to improve solubility, metabolic stability, and can form hydrogen bonds or occupy hydrophobic pockets within the kinase active site. This modification aims to improve binding affinity and potentially selectivity for JNK3.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3ccc(CN4CCOCC4)cc3)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(F)c3)ncnc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a quinazoline core (fused pyrimidine and benzene rings). Attached to the quinazoline is an amide group (-C(=O)NH2) at position 8 and a benzylamine linker (-NHCH2-phenyl) at position 4. The benzyl group is substituted with a fluorine atom at the meta position of the phenyl ring.\",\n    \"Property_Analysis\": \"Quinazoline derivatives are known scaffolds for kinase inhibitors, including JNK3. The nitrogen atoms in the quinazoline ring and the amide group can act as hydrogen bond acceptors/donors, potentially interacting with the hinge region of JNK3. The benzylamine moiety occupies a hydrophobic pocket, and the fluorine substituent influences electronic properties and potential interactions within this pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary amide might present metabolic stability or solubility issues. The meta-fluorine substitution on the benzyl ring might not provide optimal hydrophobic interactions or specific interactions within the JNK3 binding site compared to other substituents or substitution patterns often found in potent JNK3 inhibitors.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve potency and address limitations, the primary amide can be modified to a secondary amide (e.g., N-methyl amide) to potentially enhance metabolic stability or permeability while maintaining key hydrogen bonding interactions. The meta-fluoro substituent on the benzyl ring can be replaced with a group known to enhance binding in kinase hydrophobic pockets, such as a chlorine atom at the para position, which can offer stronger hydrophobic interactions and potentially better shape complementarity within the JNK3 active site.\",\n    \"Final_Target_Molecule\": \"CNC(=O)c1cccc2c(NCc3ccc(Cl)cc3)ncnc12\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccccc3)nc(N)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CC(C)n1cnc2c(NCc3ccccc3)nc(N)nc21, is an N9-isopropyl, C8-(benzylaminomethyl)-adenine derivative. It features a purine core, a key scaffold often involved in ATP-competitive kinase inhibition. Key substituents include the isopropyl group at N9, the amino group at C6, and the benzylaminomethyl group at C8.\",\n    \"Property_Analysis\": \"The purine core likely interacts with the hinge region of JNK3. The N6-amino group can act as a hydrogen bond donor, while N1 and N7 can act as acceptors. The N9-isopropyl group occupies a hydrophobic pocket near the ATP binding site. The C8-benzylaminomethyl substituent extends towards the solvent-exposed region or another sub-pocket, contributing significantly to binding affinity and potentially selectivity through hydrophobic interactions (phenyl ring) and linker flexibility.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The unsubstituted benzyl ring at the C8 position might lack specific interactions (e.g., hydrogen bonding, directed polar interactions) that could enhance binding affinity and/or selectivity for JNK3 over other kinases. The flexibility of the aminomethyl linker might also incur an entropic penalty upon binding. The relatively simple hydrophobic nature of the benzyl group might not fully exploit the features of the corresponding JNK3 subpocket.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, modifications targeting the C8 substituent are proposed. Introducing polar substituents onto the benzyl ring could establish specific interactions within the JNK3 binding site. For instance, adding a fluorine atom at the meta-position (3-position) of the phenyl ring can introduce favorable polar interactions (C-F...H-C or C-F...polar group) and potentially improve pharmacokinetic properties without significantly increasing steric bulk. This modification aims to improve binding affinity and potentially selectivity.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(NCc3cccc(F)c3)nc(N)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "COc1nc(NC(C)=O)cc(N)c1C#N",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, COc1nc(NC(C)=O)cc(N)c1C#N (2-(acetylamino)-4-amino-5-cyano-6-methoxypyridine), features a substituted pyridine core. Key functional groups include a methoxy group (electron-donating), an N-acetylamino group (potential H-bond donor/acceptor), a primary amino group (H-bond donor), and a cyano group (electron-withdrawing, H-bond acceptor). The pyridine nitrogen and adjacent amide NH are potential hinge binders.\",\n    \"Property_Analysis\": \"The aminopyridine scaffold is a known hinge-binding motif for kinases like JNK3. The substituents modulate the electronic properties, solubility, and potential interactions within the ATP-binding pocket. The N-acetyl group and amino group can form hydrogen bonds, while the methoxy and cyano groups influence polarity and interactions in specific pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-acetyl group is relatively small and conformationally flexible, potentially leading to suboptimal interactions within the hydrophobic pocket adjacent to the hinge region, limiting potency. The cyano group's position and electronic influence might not be optimal for strong JNK3 inhibition compared to other possible substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the N-acetyl group (NC(C)=O) can be replaced with a larger, more rigid moiety to enhance hydrophobic and potential pi-stacking interactions in the active site. Replacing the acetyl with a benzoyl group (C(=O)c1ccccc1) is proposed. This modification aims to better occupy the pocket near the hinge region, potentially increasing binding affinity and JNK3 inhibitory activity.\",\n    \"Final_Target_Molecule\": \"COc1nc(NC(=O)c2ccccc2)cc(N)c1C#N\"\n  }\n]"
    },
    {
        "src_smiles": "CS(=O)(=O)Nc1ccc2ccc3ncc(Cl)cc3c(=O)c2c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CS(=O)(=O)Nc1ccc2ccc3ncc(Cl)cc3c(=O)c2c1 (10-chloro-4-(methylsulfonylamino)-7H-benzo[de]pyrrolo[1,2-a]quinolin-7-one), features a methanesulfonamide group attached to an aniline moiety, which is fused to a complex, planar, polycyclic heteroaromatic core. This core contains a pyridine ring substituted with chlorine and a ketone functional group.\",\n    \"Property_Analysis\": \"The planar aromatic core likely participates in pi-stacking interactions within the ATP binding site of JNK3. The methanesulfonamide nitrogen can act as a hydrogen bond donor, potentially interacting with the hinge region backbone. The ketone oxygen could serve as a hydrogen bond acceptor. The chlorine atom occupies a specific region, likely hydrophobic, within the binding pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The affinity for JNK3 might be limited by suboptimal interactions. The methanesulfonamide group might not be the most effective hinge binder compared to other motifs. The chlorine atom, while occupying space, might not provide optimal hydrophobic interactions or could introduce selectivity issues against other kinases. The overall fit within the JNK3 active site might not be ideal for high potency.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance hydrophobic interactions and improve potency or metabolic stability, the chlorine atom on the pyridine ring can be replaced. Substituting it with a trifluoromethyl (CF3) group is a common strategy in kinase inhibitor optimization to probe a hydrophobic pocket more effectively and potentially improve binding affinity.\",\n    \"Final_Target_Molecule\": \"CS(=O)(=O)Nc1ccc2ccc3ncc(C(F)(F)F)cc3c(=O)c2c1\"\n  }\n]"
    },
    {
        "src_smiles": "Nc1c(C(=O)c2cccc(C(O)CO)c2)cnn1-c1ccc(F)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a 1-(4-fluorophenyl)-1H-pyrazol-5-amine core. Attached to the C4 position of the pyrazole is a benzoyl group, where the phenyl ring is substituted at the meta-position with a 1,2-dihydroxyethyl group (-CH(OH)CH2OH). Key components include the aminopyrazole (potential hinge binder), the 4-fluorophenyl group (hydrophobic interactions/electronics), and the substituted benzoyl moiety (pocket interactions).\",\n    \"Property_Analysis\": \"The aminopyrazole scaffold is common in kinase inhibitors, capable of forming hydrogen bonds with the kinase hinge region via the amino group and pyrazole nitrogen. The 4-fluorophenyl group explores a hydrophobic pocket. The meta-substituted benzoyl group interacts with the ATP binding site, with the dihydroxyethyl group potentially forming specific hydrogen bonds but also adding significant polarity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The meta-dihydroxyethyl group (-CH(OH)CH2OH) on the benzoyl ring introduces considerable polarity and conformational flexibility. This may lead to suboptimal binding affinity due to entropic penalties or unfavorable interactions within the JNK3 ATP pocket, which often prefers specific hydrophobic or directed polar interactions. This group might also negatively impact cell permeability and metabolic stability.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially pharmacokinetic properties, the polar and flexible dihydroxyethyl group can be replaced. A common optimization strategy is to substitute it with a smaller, less polar group that can still occupy the pocket effectively, potentially improving hydrophobic interactions or reducing entropic loss upon binding. Replacing it with a simple methyl group (CH3) at the meta position is a reasonable starting point, as methyl groups often fit well into hydrophobic subpockets within kinase active sites.\",\n    \"Final_Target_Molecule\": \"Nc1c(C(=O)c2cccc(C)c2)cnn1-c1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(C2CCCCC2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule possesses a tetracyclic core structure derived from psoralen (a furanocoumarin). Specifically, it's a benzofuro[3,2-g]chromen-7-one. A cyclohexyl substituent is attached to the pyrone ring.\",\n    \"Property_Analysis\": \"The planar aromatic system likely engages in pi-stacking interactions within the ATP-binding site of JNK3. The lipophilic cyclohexyl group might occupy a hydrophobic pocket adjacent to the active site. Furanocoumarins have shown kinase inhibitory activity, suggesting potential, albeit likely non-optimal, interaction with JNK3.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The molecule lacks strong hydrogen bond donors or acceptors typically required for potent kinase inhibition via interaction with the hinge region of JNK3 (e.g., Met111). The furan oxygen is a poor H-bond acceptor, and there are no suitable H-bond donors. The overall lipophilicity and lack of specific polar interactions might limit binding affinity and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, introduce a hydrogen bond donor capable of interacting with the kinase hinge region. Replacing the furan oxygen atom with a nitrogen atom (specifically, an NH group) transforms the core into a benzo[h]quinolin-2-one derivative. This introduces an N-H donor strategically positioned to potentially interact with the backbone carbonyl of Met111 in the JNK3 hinge region, a common interaction motif for potent kinase inhibitors.\",\n    \"Final_Target_Molecule\": \"O=c1cc(C2CCCCC2)nc2c1ccc1ccccc12\"\n  }\n]"
    },
    {
        "src_smiles": "c1ccc(COc2ccc(OCCn3cnc4ccccc43)cc2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, c1ccc(COc2ccc(OCCn3cnc4ccccc43)cc2)cc1, features a central 1,4-disubstituted phenyl ring. One substituent is a benzyloxy group (phenyl-CH2-O-). The other substituent is an oxyethyl-benzimidazole group (-O-CH2-CH2-N-benzimidazole). The molecule contains two ether linkages and an N-alkylated benzimidazole heterocycle.\",\n    \"Property_Analysis\": \"The target property is JNK3 inhibition. JNK3 is a serine/threonine kinase. Inhibitors typically compete with ATP for binding in the active site. Key interactions often involve hydrogen bonding with the kinase hinge region (e.g., Met residue) and hydrophobic interactions within the ATP binding pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The molecule possesses significant flexibility due to the two ether linkages and the ethyl chain, which can lead to an entropic penalty upon binding. The ether linkages may also be susceptible to metabolic cleavage. The benzimidazole moiety, while capable of some interactions, might not be optimally positioned or functionalized for strong hydrogen bonding with the JNK3 hinge region compared to known hinge-binding motifs.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, metabolic stability, and binding affinity: Replace the metabolically labile and flexible oxyethyl linker (-O-CH2-CH2-) connected to the central phenyl ring with a more rigid and stable amide linker (-NH-C(=O)-). Replace the benzimidazole group with a 3-aminopyridine moiety, a known strong hinge-binding element in kinase inhibitors, positioning the amino group for potential hydrogen bonding with the JNK3 hinge.\",\n    \"Final_Target_Molecule\": \"c1ccc(COc2ccc(NC(=O)c3ccnc(N)c3)cc2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrido[2,3-d]pyrimidin-7-one core. Key substituents include a methyl group on the pyridine ring (position 6), an N-methyl group on the pyrimidinone nitrogen (N8), and a 2,3-dichlorophenyl group attached to the pyrimidinone ring (position 5). The pyrido[2,3-d]pyrimidinone core acts as a hinge-binding motif typical for kinase inhibitors.\",\n    \"Property_Analysis\": \"The molecule is designed as a potential JNK3 inhibitor. Its inhibitory activity likely relies on hydrogen bonding interactions between the pyrido[2,3-d]pyrimidinone core and the JNK3 hinge region, and hydrophobic interactions primarily driven by the 2,3-dichlorophenyl group occupying a hydrophobic pocket within the ATP-binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 2,3-dichlorophenyl group might present limitations. While providing hydrophobicity, the specific substitution pattern might not be optimal for potency or selectivity against JNK3 versus other kinases. Dichloro substitutions can sometimes lead to metabolic liabilities or poor physicochemical properties (e.g., high lipophilicity, low solubility). The steric bulk and electronic nature might not perfectly complement the JNK3 active site.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, focus on modifying the dichlorophenyl group to enhance interactions within the hydrophobic pocket and potentially improve selectivity or physicochemical properties. Replace the 2,3-dichlorophenyl group with a 3-chloro-4-fluorophenyl group. This modification retains halogen interactions while potentially offering improved metabolic stability, altered electronic properties due to fluorine, and potentially better complementarity with the JNK3 binding site compared to the dichloro analog. The fluoro group can also engage in favorable interactions.\",\n    \"Final_Target_Molecule\": \"Cc1ncc2cc(-c3ccc(F)c(Cl)c3)c(=O)n(C)c2n1\"\n  }\n]"
    },
    {
        "src_smiles": "c1cnc(-c2c[nH]c3ncnc(N4CCOCC4)c23)cn1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrrolo[2,3-d]pyrimidine core. Attached to the C4 position of the pyrrole ring is a pyrimidin-5-yl group. The C6 position of the pyrimidine part of the core is substituted with a morpholin-4-yl group. The pyrrole nitrogen (N7) is unsubstituted (NH).\",\n    \"Property_Analysis\": \"The target property is JNK3 inhibition. JNK3 is a serine/threonine kinase predominantly expressed in the brain, heart, and testes. Its inhibition is pursued for potential therapeutic benefits in neurodegenerative diseases and ischemic injury by blocking apoptotic signaling pathways.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The morpholine group at C6 might not establish optimal interactions within the solvent-exposed region of the JNK3 ATP-binding site, potentially limiting potency or selectivity. The unsubstituted pyrrole N7-H could be a site for phase II metabolism (glucuronidation) or might form unfavorable interactions, impacting pharmacokinetic properties or potency.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition and pharmacokinetic properties, replace the morpholine moiety with a 4-methylpiperazin-1-yl group. This modification introduces a basic nitrogen which might form favorable interactions (e.g., salt bridge with acidic residues like Asp169 in the hinge region if conformation allows, or improved solvent interactions) and the methyl group can explore a small hydrophobic pocket. This change aims to enhance binding affinity and potentially improve ADME profile compared to morpholine.\",\n    \"Final_Target_Molecule\": \"CN1CCN(c2ncnc3c(c[nH]c32)-c3cncnc3)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "Fc1ccc(-c2nc[nH]c2-c2ccncc2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central imidazole ring substituted at the 2-position with a 4-fluorophenyl group and at the 4-position with a 4-pyridyl group. Key features include the imidazole N-H (potential H-bond donor/acceptor), the pyridine nitrogen (H-bond acceptor), and the 4-fluorophenyl group (hydrophobic interactions, potential halogen bond).\",\n    \"Property_Analysis\": \"Imidazole-based scaffolds are common in kinase inhibitors, including JNK3 inhibitors. The pyridine and fluorophenyl groups likely occupy hydrophobic pockets within the ATP binding site. The imidazole N-H often forms a crucial hydrogen bond with the hinge region (e.g., Met111 backbone NH) of kinases.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific substitutions (4-pyridyl and 4-fluorophenyl) may not provide optimal interactions for high JNK3 potency or selectivity. The 4-pyridyl group's basicity might negatively impact cell permeability or metabolic stability. The binding affinity might be moderate, requiring optimization for improved inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the 4-pyridyl group can be replaced to explore alternative interactions or modulate physicochemical properties. Replacing it with a 3-aminophenyl group introduces a hydrogen bond donor (the amino group) which could potentially form favorable interactions with residues in the JNK3 active site, a common strategy in kinase inhibitor design to improve potency.\",\n    \"Final_Target_Molecule\": \"Nc1cccc(-c2[nH]cnc2-c2ccc(F)cc2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(O)CCSc1ccc2ccccc2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, 3-((quinolin-4-yl)thio)propanoic acid (SMILES: O=C(O)CCSc1ccc2ccccc2n1), features a quinoline core linked via a thioether bridge to a propanoic acid side chain. Key functional groups include the quinoline nitrogen, the thioether sulfur, and the terminal carboxylic acid.\",\n    \"Property_Analysis\": \"The quinoline scaffold is present in various kinase inhibitors, suggesting potential for binding to the ATP site of JNK3. The thioether linker provides flexibility, and the carboxylic acid group can form hydrogen bonds or ionic interactions with receptor residues. The overall lipophilicity and electronic distribution influence binding affinity and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal carboxylic acid group is highly polar and likely ionized at physiological pH. This can limit cell permeability and oral bioavailability, potentially reducing efficacy in cell-based assays or in vivo. The thioether linkage might be susceptible to metabolic oxidation (S-oxidation). The flexibility of the linker might lead to entropic penalties upon binding. The unsubstituted quinoline might lack specific interactions needed for high JNK3 affinity or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To address the limitations, particularly poor permeability associated with the carboxylic acid, replace the carboxylic acid with a less acidic bioisostere or functional group capable of similar interactions. Converting the carboxylic acid to a primary amide (CONH2) is a common strategy to reduce acidity and potentially improve permeability while retaining hydrogen bonding capacity. This modification targets the pharmacokinetic profile without drastically altering the core binding pharmacophore initially.\",\n    \"Final_Target_Molecule\": \"O=C(N)CCSc1ccc2ccccc2n1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(O)c1cnc2c(ccc3ccccc32)c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, O=C(O)c1cnc2c(ccc3ccccc32)c1 (Benz[h]quinoline-4-carboxylic acid), is a planar, tetracyclic heteroaromatic system. It features a quinoline ring fused to a phenanthrene backbone, with a carboxylic acid group attached to the quinoline ring at position 4.\",\n    \"Property_Analysis\": \"The planar aromatic system can potentially fit into the relatively flat ATP-binding site of kinases like JNK3, engaging in pi-stacking interactions. The quinoline nitrogen can act as a hydrogen bond acceptor, potentially interacting with the hinge region backbone amide NH of Met111 in JNK3. The carboxylic acid group provides additional hydrogen bond donor/acceptor capabilities and potential for ionic interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The carboxylic acid group introduces a negative charge at physiological pH, which can hinder cell permeability and oral bioavailability. Its acidity might also lead to non-optimal interactions or metabolic liabilities. The unsubstituted nature of the larger aromatic system may lack specific interactions with hydrophobic pockets within the JNK3 active site, potentially limiting potency and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially pharmacokinetic properties, the carboxylic acid group can be replaced with a primary amide (-CONH2). This modification removes the negative charge, potentially improving permeability. The amide group retains hydrogen bonding capabilities (both donor N-H and acceptor C=O), which can potentially establish favorable interactions within the ATP binding site, possibly mimicking interactions made by known JNK3 inhibitors.\",\n    \"Final_Target_Molecule\": \"NC(=O)c1cnc2c(ccc3ccccc32)c1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1cc(C)n(-c2ccc(C(=O)Nc3sccc3C(N)=O)cc2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central phenyl ring substituted with a 3,5-dimethyl-1H-pyrazol-1-yl group at one position and an amide linkage at the para position. The amide nitrogen is connected to a 2-carboxamidothiophen-5-yl group. Key fragments are: 3,5-dimethylpyrazole, p-phenylene linker, amide linker, and 5-(aminocarbonyl)thiophen-2-yl.\",\n    \"Property_Analysis\": \"The molecule possesses features common to kinase inhibitors, particularly ATP-competitive inhibitors. The pyrazole group likely occupies a hydrophobic pocket. The phenyl ring acts as a scaffold. The amide group and the thiophene carboxamide moiety are expected to interact with the hinge region and other residues within the JNK3 ATP-binding site, primarily through hydrogen bonds.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The thiophene-2-carboxamide group, while capable of hydrogen bonding, might not provide optimal interactions (e.g., hydrogen bond vectors, hydrophobic contacts) within the JNK3 active site compared to other known hinge-binding motifs. The overall potency might be limited by the specific geometry and electronic properties of this substituent.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the 5-(aminocarbonyl)thiophen-2-yl group attached to the amide nitrogen can be replaced with a moiety known to form stronger or more favorable interactions with the JNK3 hinge region. A 4-aminopyridine group is a common and effective hinge-binding motif in kinase inhibitors. Replacing the thiophene carboxamide with 4-aminopyridine aims to enhance hydrogen bonding interactions with the kinase hinge backbone.\",\n    \"Final_Target_Molecule\": \"Cc1cc(C)n(-c2ccc(C(=O)Nc3ccncc3N)cc2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1[nH]c2ccc(Cl)cc2c1-c1ccnc(N2CCCC2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 2-methyl-5-chloro-1H-indole core attached at the 3-position to a 4-pyrimidinyl ring. The pyrimidine ring is further substituted at the 2-position with a pyrrolidin-1-yl group.\",\n    \"Property_Analysis\": \"The indole and pyrimidine moieties are common scaffolds in kinase inhibitors, suggesting potential interaction with the ATP-binding site of JNK3. The pyrrolidine group likely occupies a hydrophobic pocket, while the chlorine atom contributes to lipophilicity and potential halogen bonding. The indole NH can act as a hydrogen bond donor.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The pyrrolidine group, while potentially occupying a hydrophobic pocket, might not be optimal for maximizing binding affinity or selectivity. Its basicity and lipophilicity could negatively impact pharmacokinetic properties (e.g., solubility, metabolic stability, hERG inhibition). The overall lipophilicity driven by the chloro and pyrrolidine groups might be too high.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially enhance pharmacokinetic properties, replace the pyrrolidine group with a morpholine ring. Morpholine maintains a cyclic amine structure but introduces an oxygen atom, which can act as a hydrogen bond acceptor and often improves solubility and metabolic stability compared to pyrrolidine, potentially leading to better overall profile including JNK3 inhibitory activity.\",\n    \"Final_Target_Molecule\": \"Cc1[nH]c2ccc(Cl)cc2c1-c1ccnc(N3CCOCC3)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(C)C)c2)[nH]1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(C)C)c2)[nH]1, features a central 2-mercaptoimidazole core substituted at position 4 with a 4-fluorophenyl ring and at position 5 with a 4-(isopropoxy)pyridin-2-yl ring. The imidazole nitrogen is protonated (nH). The key functional groups are the imidazole ring (potential H-bond donor/acceptor), the methylthio group, the fluorophenyl ring (hydrophobic interactions, potential halogen bonding), the pyridine ring (H-bond acceptor), and the isopropoxy group (hydrophobic).\",\n    \"Property_Analysis\": \"JNK3 inhibition typically involves interactions with the kinase hinge region (H-bonding) and occupancy of the ATP binding site's hydrophobic pockets. The imidazole core (specifically the NH and potentially the unsubstituted nitrogen) could interact with the JNK3 hinge. The fluorophenyl and isopropoxy-pyridine moieties likely occupy hydrophobic regions of the active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylthio group (CS-) might not be optimal for potency or selectivity; it could introduce unfavorable steric or electronic interactions or metabolic liabilities. The isopropoxy group, while occupying a pocket, might not provide optimal interactions or could limit solubility. The overall combination might lack sufficient potency or kinase selectivity for JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"Optimization focuses on enhancing hinge binding and interactions within the hydrophobic pockets, while improving drug-like properties. Strategy: 1) Replace the potentially suboptimal methylthio group (CS-) at position 2 with hydrogen (H) to simplify the structure and potentially improve binding affinity by removing steric hindrance or unfavorable interactions near the hinge-binding region. 2) Replace the isopropoxy group on the pyridine ring with a morpholinoethoxy group (-OCCN1CCOCC1). Morpholine groups are often incorporated into kinase inhibitors to improve solubility, metabolic stability, and potentially form additional interactions.\",\n    \"Final_Target_Molecule\": \"c1[nH]c(-c2ccc(F)cc2)c(-c2ccnc(OCCN3CCOCC3)c2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CCn1ncc(C2=NOC(C(=O)Nc3cccc(C(C)=O)c3)C2)c1C",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central isoxazole ring linked via an amide bond to a meta-acetylphenyl group. The other side of the isoxazole is connected to an N-ethyl-5-methylpyrazole ring.\",\n    \"Property_Analysis\": \"The molecule possesses hydrogen bond donors (amide NH) and acceptors (amide C=O, isoxazole N, O, pyrazole Ns, acetyl C=O) and aromatic rings capable of hydrophobic and pi-stacking interactions, which are potential determinants for JNK3 binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The meta-acetylphenyl group might not be optimal for fitting into the JNK3 binding pocket. The acetyl group could introduce suboptimal steric or electronic interactions, or potential metabolic liabilities, limiting the overall inhibitory potency.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the meta-acetylphenyl group with a 3-pyridyl group. The pyridine nitrogen can act as a hydrogen bond acceptor, potentially forming a favorable interaction with residues in the JNK3 active site, a common feature in many kinase inhibitors.\",\n    \"Final_Target_Molecule\": \"CCn1ncc(C2=NOC(C(=O)Nc3cccc(n)c3)C2)c1C\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cc(C2CCCCC2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a benzocoumarin core (a fusion of coumarin and benzene rings). A cyclohexyl group is attached at the 3-position of the coumarin ring.\",\n    \"Property_Analysis\": \"Benzocoumarin derivatives can act as kinase inhibitors. The scaffold provides a planar system potentially fitting into kinase active sites. The cyclohexyl group adds lipophilicity, which might influence cell permeability and binding, but its specific contribution to JNK3 inhibition is unclear without data.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky, non-polar cyclohexyl group might not provide specific favorable interactions (like hydrogen bonding) within the JNK3 active site, potentially limiting potency. It might also contribute to poor solubility or lack of selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the cyclohexyl group with a heterocycle known to enhance kinase interactions. Introducing a pyridine ring, specifically a 4-pyridyl group, can provide a hydrogen bond acceptor (nitrogen atom) and potentially better shape complementarity within the JNK3 binding pocket, a common strategy for improving kinase inhibitor potency.\",\n    \"Final_Target_Molecule\": \"O=c1cc(c2ccncc2)oc2c1ccc1ccccc12\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)c1ccc(=O)n(Cc2ccc3c(c2)OCO3)c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central pyridone ring substituted with a methyl ester group and an N-linked benzyl group. The benzyl group itself is substituted with a methylenedioxy ring (piperonyl moiety). Key groups include the methyl ester, the pyridone carbonyl, the piperonyl group, and the methylene linker.\",\n    \"Property_Analysis\": \"The pyridone core is a common scaffold in kinase inhibitors, potentially interacting with the hinge region of JNK3. The N-benzylpiperonyl group occupies a hydrophobic pocket. The methyl ester might interact with polar residues or water molecules in the active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methyl ester group is susceptible to hydrolysis by esterases, potentially leading to poor metabolic stability and reduced duration of action. Its size and polarity might not be optimal for interactions within the JNK3 active site compared to other potential polar groups like amides or nitriles which can offer different hydrogen bonding patterns.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the metabolically labile methyl ester group with a more stable primary amide group (-CONH2). This change aims to improve metabolic stability while retaining or enhancing polar interactions within the JNK3 active site through hydrogen bonding (donor and acceptor capabilities).\",\n    \"Final_Target_Molecule\": \"NC(=O)c1ccc(=O)n(Cc2ccc3c(c2)OCO3)c1\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCCC(O)C3)nc12, features a 1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one core, known to act as a hinge-binder in kinases. It is substituted with a methyl group at the N1 position of the pyrazole ring, an (R)-3-hydroxypiperidin-1-yl group at the C3 position, and a 2,4-difluorophenoxy group at the C6 position.\",\n    \"Property_Analysis\": \"The pyrazolo[3,4-d]pyrimidin-4-one core likely interacts with the hinge region of JNK3 via hydrogen bonds. The (R)-3-hydroxypiperidine moiety can potentially form hydrogen bonds and occupy the ribose pocket, contributing to affinity and possibly selectivity. The 2,4-difluorophenoxy group occupies a solvent-exposed pocket and contributes to binding through hydrophobic and potential halogen bond interactions. This combination of features suggests the molecule possesses JNK3 inhibitory activity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 2,4-difluorophenoxy group at the C6 position, while contributing to affinity, might not provide optimal interactions within the JNK3 active site compared to other possible substituents, potentially limiting overall potency and selectivity against related kinases. The existing interactions mediated by the (R)-3-hydroxypiperidine group might also be suboptimal for maximizing JNK3 inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the C6 substituent (2,4-difluorophenoxy) is targeted for modification. This group is replaced with a 4-(pyridin-4-yl)aniline moiety. This modification aims to introduce potentially stronger interactions within the JNK3 binding site, leveraging known SAR for JNK inhibitors where similar anilinopyridine groups have shown significant potency improvements. The N1-methyl and C3-(R)-3-hydroxypiperidine groups are retained.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(Nc2ccc(c3ccccn3)cc2)cc2cnc(N3CCCC(O)C3)nc12\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(Nc1ccc2c(c1)OCO2)C1CC(c2c(F)cccc2Cl)=NO1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an isoxazoline core substituted with a 2-chloro-6-fluorophenyl group. This core is attached via a methylene linker to an amide group. The amide nitrogen is connected to a 1,3-benzodioxole ring system.\",\n    \"Property_Analysis\": \"The molecule contains common pharmacophores for kinase inhibition. The isoxazoline-amide core likely serves as a scaffold anchoring the molecule in the ATP binding site. The 2-chloro-6-fluorophenyl group probably occupies a hydrophobic pocket, with the ortho halogens potentially influencing torsional angles and interaction strength. The benzodioxole group interacts with another region, possibly solvent-exposed or a secondary pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 1,3-benzodioxole moiety might not provide optimal interactions for JNK3 inhibition. It lacks strong hydrogen bond donor/acceptor capabilities beyond the ether oxygens (which are poorly positioned) and might have suboptimal size or electronic properties for the target subpocket. Additionally, benzodioxole groups can sometimes be associated with metabolic liabilities (CYP inhibition). The overall potency might be limited by the interactions mediated by this group.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the 1,3-benzodioxole group can be replaced with a moiety capable of forming more specific or stronger interactions, such as hydrogen bonds. A pyridine ring, specifically 4-pyridyl, is proposed as a replacement. The pyridine nitrogen can act as a hydrogen bond acceptor, potentially interacting with backbone amides or specific residues in the JNK3 active site, and may improve physicochemical properties.\",\n    \"Final_Target_Molecule\": \"O=C(Nc1ccncc1)C1CC(c2c(F)cccc2Cl)=NO1\"\n  }\n]"
    },
    {
        "src_smiles": "Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 2,4-dianilinopyrimidine core. The aniline group at the 2-position is substituted with a chlorine atom on the phenyl ring (2-chloroaniline). The aniline group at the 4-position is substituted at its para-position with a morpholine ring (4-(morpholin-4-yl)aniline).\",\n    \"Property_Analysis\": \"The diaminopyrimidine core acts as a hinge-binder, crucial for kinase inhibition. The substituted aniline groups occupy the hydrophobic pockets of the ATP binding site. The morpholine group often contributes to solubility and potency by interacting with the solvent-exposed region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The morpholine group, while conferring solubility, might not provide optimal interactions within the specific topology of the JNK3 ATP binding site's solvent-exposed region. Its size and lack of specific hydrogen bonding donors might limit potency or selectivity for JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the morpholine moiety will be replaced with a piperidin-4-ol group. This modification introduces a hydroxyl group capable of acting as both a hydrogen bond donor and acceptor, potentially forming specific interactions within the JNK3 active site that were not possible with morpholine. The piperidine ring maintains a similar cyclic amine structure but with altered conformation and polarity.\",\n    \"Final_Target_Molecule\": \"Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCC(O)CC3)cc2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCc3ccccc3)c2)[nH]1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central thiazole ring substituted at position 2 with a methylthio group (SC), at position 4 with a 4-fluorophenyl group, and at position 5 with a pyridine ring bearing a benzyloxy substituent. The thiazole ring nitrogen is protonated (nH).\",\n    \"Property_Analysis\": \"The molecule possesses features common in kinase inhibitors: heterocyclic core (thiazole), potential H-bond acceptors/donors (thiazole N, pyridine N), and hydrophobic groups (fluorophenyl, benzyloxy pyridine, methylthio). These groups can interact with the ATP binding site of JNK3.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylthio group might offer suboptimal interactions or be metabolically unstable. The large and flexible benzyloxy pyridine substituent could lead to high lipophilicity, poor pharmacokinetics, non-specific binding, or suboptimal fit within the JNK3 active site, potentially limiting potency and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition and improve drug-like properties, optimization focuses on two points: 1) Replace the methylthio group at position 2 with an amino group (NH2) to introduce a potential hydrogen bond donor for improved interaction, potentially with the kinase hinge region. 2) Replace the bulky and flexible benzyloxy pyridine group at position 5 with a smaller, less lipophilic, and more rigid pyridin-4-yl group to reduce size, decrease lipophilicity, and potentially improve binding specificity and pharmacokinetic profile.\",\n    \"Final_Target_Molecule\": \"Nc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)(C)c1cnc(CSc2cnc(NC(=O)c3ccccc3)s2)o1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central thiadiazole ring linked via a methylene (-CH2-) bridge to a 5-(tert-butyl)oxazole moiety on one side, and an amide linkage to a benzoyl group on the other side. Key fragments include: tert-butyl group, oxazole ring, methylene linker, thiadiazole ring, amide linker, and phenyl ring.\",\n    \"Property_Analysis\": \"The molecule incorporates structural motifs common in kinase inhibitors. The amide NH and carbonyl oxygen, along with nitrogen atoms in the heterocycles (oxazole, thiadiazole), can participate in hydrogen bonding interactions within the JNK3 ATP-binding site, particularly with the hinge region. The tert-butyl and phenyl groups provide hydrophobic interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky tert-butyl group might cause steric hindrance or suboptimal fit within the hydrophobic pocket near the gatekeeper residue. The unsubstituted phenyl ring might not fully exploit potential interactions in its binding region. The overall combination of fragments might not achieve the optimal balance of potency, selectivity, and physicochemical properties for a JNK3 inhibitor.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the bulky tert-butyl group with a potentially more favorable group for hydrophobic interactions, such as a phenyl ring, to probe deeper pocket interactions or pi-stacking. Introduce a substituent on the terminal phenyl ring, like a para-fluoro group, to enhance binding affinity through potential polar or halogen bond interactions and improve metabolic stability.\",\n    \"Final_Target_Molecule\": \"c1ccc(cc1)c2cnc(CSc3cnc(NC(=O)c4ccc(F)cc4)s3)o2\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(N3CCN(C(=O)Nc4ccccn4)CC3)c2cc1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a quinazoline core substituted at the 4-position with a piperazine ring. This piperazine is further functionalized with a urea moiety linking to a pyridine ring. The quinazoline core also bears two methoxy substituents at positions 6 and 7.\",\n    \"Property_Analysis\": \"JNK3 inhibitors typically bind to the ATP-binding site of the kinase. The source molecule possesses potential hinge-binding elements (quinazoline nitrogens, urea group) and groups (piperazine, pyridine) that can occupy hydrophobic pockets and form hydrogen bonds within the active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific substitutions, particularly the dimethoxy groups on the quinazoline core and the terminal pyridine ring, may not be optimal for potent and selective JNK3 inhibition. The methoxy groups might introduce steric bulk or unfavorable interactions, while the pyridine ring might not optimally occupy the relevant subpockets for JNK3 compared to other possible substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, simplify the quinazoline core by removing the methoxy groups. This reduces steric hindrance and molecular weight, potentially improving ligand efficiency and exploring the requirement for substitution in that region. The core quinazoline, piperazine-urea linker, and pyridine head group are retained as a starting scaffold for optimization.\",\n    \"Final_Target_Molecule\": \"O=C(Nc1ccccn1)N1CCN(c2ncnc3ccccc23)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCCC(=O)Nc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an imidazo[2,1-f]purine core. Key substituents include: 1) A butanamide group attached to the amino group at C6 (N6 position). 2) A 4-methoxybenzylamine group linked via a methylene bridge to C2. 3) An isopropyl group attached to the N9 position of the purine ring system.\",\n    \"Property_Analysis\": \"The molecule is likely designed as a kinase inhibitor, targeting the ATP-binding site. The imidazo[2,1-f]purine core mimics the adenine base of ATP. The N6-butanamide can form hydrogen bonds, potentially with the kinase hinge region. The 4-methoxybenzylamine group likely occupies a hydrophobic pocket, with the methoxy group potentially forming specific interactions. The N9-isopropyl group occupies the ribose pocket area.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The linear butanamide group at N6 might possess excessive flexibility or suboptimal hydrophobic interactions within its binding site, potentially limiting potency or introducing unfavorable entropic costs upon binding. Its size and shape might not perfectly complement the target pocket for optimal JNK3 inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the butanamide group will be modified. Replace the linear butyl chain with a cyclopropyl group to introduce conformational rigidity and potentially improve hydrophobic interactions and ligand efficiency. This retains the crucial amide hydrogen bonding motif while altering the shape and lipophilicity profile.\",\n    \"Final_Target_Molecule\": \"c1cc1C(=O)Nc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(-n2c(=O)c(C)nc3cnc(N4CCNCC4)nc32)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pteridinone core substituted with a methyl group. A piperazine moiety is attached at the 6-position of the pteridinone ring. A para-methoxyphenyl group is attached to the N1 position of the pteridinone ring.\",\n    \"Property_Analysis\": \"The pteridinone core likely acts as a hinge-binding motif, common in kinase inhibitors. The piperazine group extends towards the solvent-exposed region, potentially influencing solubility and interactions with the protein surface. The methoxyphenyl group occupies a specific pocket, likely hydrophobic, influencing binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The para-methoxy group on the phenyl ring might not be optimal for hydrophobic interactions within the binding pocket. It could also be susceptible to metabolic O-demethylation. The unsubstituted terminal nitrogen of the piperazine might offer limited interactions or could be a site for metabolism.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the para-methoxy group on the phenyl ring with a para-trifluoromethyl (CF3) group. The CF3 group is strongly electron-withdrawing, metabolically more stable than methoxy, and can enhance hydrophobic interactions within the binding site, potentially increasing JNK3 inhibition.\",\n    \"Final_Target_Molecule\": \"FC(F)(F)c1ccc(-n2c(=O)c(C)nc3cnc(N4CCNCC4)nc32)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrimido[4,5-b]azepin-4(3H)-one core. Key substituents include an N-methyl group at position 3, a 2,4-difluorophenoxy group at position 5, and a piperidin-4-ol moiety linked via its nitrogen atom to position 8 of the pyrimidine ring.\",\n    \"Property_Analysis\": \"The pyrimido[4,5-b]azepinone scaffold is known in kinase inhibitors. The difluorophenoxy group likely participates in hydrophobic interactions and potential halogen bonding. The piperidin-4-ol group, especially the hydroxyl, is crucial for potential hydrogen bonding interactions within the JNK3 ATP binding site, likely targeting the hinge region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The piperidin-4-ol moiety might not offer optimal geometry or hydrogen bonding vectors for maximum JNK3 potency and selectivity due to its conformation and flexibility. The linker to the core might not be ideal for presenting the hydroxyl group effectively. Additionally, selectivity over other kinases could be limited.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the piperidin-4-ol group will be replaced with (S)-pyrrolidin-3-ol. This modification retains the essential hydroxyl group for hinge binding but alters the ring size and conformation, potentially leading to a better fit and improved interactions within the JNK3 active site. The smaller, potentially more rigid pyrrolidine ring might offer better positioning of the hydroxyl group.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3C[C@@H](O)CC3)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(-n2c(=O)cnc3cnc(Oc4cccc(Cl)c4)nc32)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pteridin-4(3H)-one core. It is substituted at the N3 position with a p-methoxyphenyl group (COc1ccc(-n2...)cc1) and at the C7 position with a m-chlorophenoxy group (...cnc(Oc4cccc(Cl)c4)nc32). The pteridinone core can act as a hinge-binder in kinases, while the substituents occupy other regions of the ATP binding site.\",\n    \"Property_Analysis\": \"JNK3 (c-Jun N-terminal kinase 3) is a serine/threonine kinase. Inhibition typically involves binding to the ATP-binding site. Potent inhibitors often form hydrogen bonds with the hinge region and make favorable interactions (hydrophobic, van der Waals, hydrogen bonding) within the specificity pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The m-chlorophenoxy group at C7 might not provide optimal interactions within the relevant JNK3 pocket. Its size, shape, and electronic properties might be suboptimal for high affinity binding compared to known potent JNK3 motifs. The p-methoxyphenyl group might also lack specific features for strong interaction or could be improved for better potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the C7 m-chlorophenoxy group with a moiety known to enhance JNK3 inhibition. Based on known JNK3 inhibitor SAR, an aminopyrazole group often provides favorable interactions. Specifically, replacing -Oc4cccc(Cl)c4 with a 1H-pyrazol-4-ylamino group (-NH-c1cn[nH]c1) introduces potential hydrogen bond donors/acceptors and a different scaffold shape expected to improve binding affinity to JNK3.\",\n    \"Final_Target_Molecule\": \"COc1ccc(-n2c(=O)cnc3cnc(Nc4cn[nH]c4)nc32)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CCNCCC(=O)Nc1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCNCCC(=O)Nc1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C, assuming CCNCCC(=O) represents a pentanoyl group (CCCCC(=O)), features an N-(pyrrol-3-yl)pentanamide structure. The pyrrole ring is substituted at positions 2 and 5 with methyl groups and at position 4 with a vinyl linker (=C) connecting to a 5-fluoro-indolin-2-one moiety.\",\n    \"Property_Analysis\": \"The core structure (dimethylpyrrole linked via a vinyl bridge to fluoro-indolinone) is a known scaffold for kinase inhibition, likely interacting with the ATP binding site. The indolinone often binds to the hinge region. The N-pentanoyl group likely occupies a hydrophobic pocket adjacent to the ATP site. The specific substitutions influence potency and selectivity towards JNK3.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The linear n-pentyl chain of the pentanamide group (assuming CCCCC(=O)) possesses significant conformational flexibility. This flexibility can lead to an entropic penalty upon binding, potentially reducing binding affinity. Furthermore, its length and linear shape might not be optimal for hydrophobic interactions within the specific pocket of JNK3, potentially limiting potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To address the flexibility and potentially suboptimal shape of the n-pentyl group, replace it with a smaller, more rigid hydrophobic moiety. Replacing the pentanoyl group (CCCCC(=O)) with a cyclopropylacetyl group (C1CC1C(=O)) introduces rigidity and alters the shape, potentially leading to improved interactions within the hydrophobic pocket and increased binding affinity or selectivity for JNK3.\",\n    \"Final_Target_Molecule\": \"C1CC1C(=O)Nc1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C\"\n  }\n]"
    },
    {
        "src_smiles": "NC1=NC(CF)(c2cc(Oc3ncccn3)ccc2F)CC(C(F)(F)F)O1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a substituted oxazoline ring. Key groups include: an amino group (=N-C(N)=), a monofluoromethyl group (CF), a trifluoromethyl group (C(F)(F)F), and a fluoro-phenyl ring substituted with a pyrimidine ether (c2cc(Oc3ncccn3)ccc2F). The oxazoline ring contains two chiral centers.\",\n    \"Property_Analysis\": \"The molecule possesses potential kinase inhibitory features. The amino group on the oxazoline could potentially interact with the kinase hinge region, although oxazolines are not canonical hinge binders. The fluoro-phenyl-pyrimidine ether moiety likely occupies hydrophobic pockets near the ATP binding site. Fluorine atoms modulate electronic properties, metabolic stability, and binding affinity. The CF and CF3 groups significantly increase lipophilicity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The amino-oxazoline core is a relatively weak and uncommon hinge-binding motif compared to standard motifs like aminopyrimidines or aminopyridines, potentially limiting potency. The oxazoline ring might be susceptible to hydrolysis or metabolic cleavage. The combined lipophilicity from CF, CF3, F, and the pyrimidine ether is likely high (high LogP), potentially leading to poor solubility, non-specific binding, and ADME issues.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the amino-oxazoline core with a proven hinge-binding scaffold, such as 2-aminopyrimidine, to enhance interaction with the JNK3 hinge residues. Simplify the structure to remove chiral centers and potentially reduce metabolic liability. Modify or replace the fluoro-phenyl-pyrimidine ether moiety and potentially the CF group to optimize potency and reduce overall lipophilicity. For instance, retain the trifluoromethyl group, often beneficial for potency, but replace the CF group and the complex ether substituent with a simpler fluorophenyl group.\",\n    \"Final_Target_Molecule\": \"NC1=NC(C(F)(F)F)=CC(c2ccc(F)cc2)=N1\"\n  }\n]"
    },
    {
        "src_smiles": "Oc1ccc(Nc2nc(-c3ccc(N4CCOCC4)cc3)cs2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central 2-aminothiazole core. The amino group is substituted with a 4-hydroxyphenyl ring. The C2 position of the thiazole ring is substituted with a 4-morpholinophenyl group.\",\n    \"Property_Analysis\": \"The target property is JNK3 inhibition. The 2-aminothiazole scaffold is a known kinase inhibitor motif. The N-aryl group likely interacts with the kinase hinge region via hydrogen bonding. The C2-aryl group interacts with other pockets in the ATP binding site. The morpholine group enhances solubility, and the hydroxyl group can potentially form hydrogen bonds.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 4-hydroxyphenyl group might not provide optimal hydrogen bonding interactions with the JNK3 hinge region compared to other known hinge-binding motifs, potentially limiting potency. The phenolic hydroxyl group can be a site for phase II metabolism (glucuronidation), potentially leading to poor pharmacokinetic properties. Selectivity over other kinases might also be an issue.\",\n    \"Optimization_for_Source_Molecule\": \"To improve hinge binding interactions, the 4-hydroxyphenyl group will be replaced with a 3-aminopyridine moiety. The pyridine nitrogen and the amino group are expected to form stronger and more favorable hydrogen bonds with the JNK3 hinge residues (like Met149). The 4-morpholinophenyl group will be retained as it often contributes positively to potency and provides good physicochemical properties.\",\n    \"Final_Target_Molecule\": \"c1cncc(Nc2nc(-c3ccc(N4CCOCC4)cc3)cs2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "O=c1cnc2cnc(OCc3ccccc3)nc2n1Cc1ccc(F)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrazolo[3,4-d]pyrimidine core, which is a common scaffold for kinase inhibitors, mimicking the adenine base of ATP. It possesses an oxo group at the C4 position, likely involved in hinge binding. An N1-(4-fluorobenzyl) group is attached to the pyrazole nitrogen, extending towards the solvent-exposed region. A C6-benzyloxy group occupies the hydrophobic pocket typically targeted by kinase inhibitors.\",\n    \"Property_Analysis\": \"The pyrazolo[3,4-d]pyrimidin-4-one core is well-established for ATP-competitive kinase inhibition. The C4=O group is expected to form crucial hydrogen bonds with the kinase hinge region backbone amides (e.g., Met146 in JNK3). The N1-(4-fluorobenzyl) group likely contributes to potency and potentially selectivity through interactions in a hydrophobic pocket or solvent channel. The C6-benzyloxy group engages with a hydrophobic pocket adjacent to the ATP binding site, but its flexibility might limit optimal binding affinity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation for potent JNK3 inhibition might be the C6-benzyloxy substituent. Its flexibility could lead to an entropic penalty upon binding, and it lacks specific directional interactions (like hydrogen bonds) often exploited for higher affinity and selectivity within the hydrophobic pocket. Furthermore, the ether linkage could be metabolically labile.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the flexible C6-benzyloxy group will be replaced with a more rigid and potentially interactive group. An anilino moiety, specifically 4-chloroaniline, is proposed. The N-H group of the aniline can act as a hydrogen bond donor, potentially interacting with backbone carbonyls (like Glu143) or the gatekeeper residue (Met144) vicinity in JNK3, while the chlorophenyl ring maintains hydrophobic interactions within the pocket, potentially enhancing affinity and selectivity over the original benzyloxy group.\",\n    \"Final_Target_Molecule\": \"O=c1c(Nc2ccc(Cl)cc2)ncc2n1Cc1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "O=C(CSc1nc2ccccc2c(=O)n1CCCO)NCc1ccccc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a quinazolinone core fused with a benzene ring, functionalized with a hydroxypropoxy group on one nitrogen. An amide linker connects this core via a thioether bridge to a benzyl group. Key components include the quinazolinone heterocycle, thioether linker, amide bond, hydroxypropoxy chain, and a terminal phenyl ring.\",\n    \"Property_Analysis\": \"The quinazolinone core is a known scaffold for kinase inhibitors, likely interacting with the ATP binding site's hinge region. The benzylamide moiety likely occupies a hydrophobic pocket adjacent to the ATP site. The hydroxypropoxy group might interact with the solvent-exposed region or specific polar residues. The thioether provides flexibility.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal unsubstituted phenyl ring of the benzylamide group might offer suboptimal hydrophobic interactions within the target JNK3 pocket. Its metabolic stability could also be a concern (e.g., potential for hydroxylation). Flexibility in the linker and side chain might lead to entropic penalties upon binding.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the terminal phenyl ring can be modified to improve interactions within the hydrophobic pocket and potentially enhance metabolic stability. Introducing a small electron-withdrawing group like fluorine at the meta-position (3-position) of the phenyl ring can modulate electronic properties and potentially improve binding affinity through specific interactions (e.g., ortho-fluoro effect, interaction with backbone C=O) or by displacing unfavorable water molecules, without significantly increasing size.\",\n    \"Final_Target_Molecule\": \"O=C(CSc1nc2ccccc2c(=O)n1CCCO)NCc1cccc(F)c1\"\n  }\n]"
    },
    {
        "src_smiles": "CCC(C)(C)Nc1c(C#N)cnc2cnc(NCc3cccnc3)cc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrido[2,3-b]pyrazine core. Key substituents include a bulky tert-pentylamino group at position 8 (N8), a cyano group at position 7 (C7), and a (pyridin-3-ylmethyl)amino group attached via a methylene linker at position 2 (C2). The pyrido[2,3-b]pyrazine is a known kinase inhibitor scaffold. The C2 substituent likely interacts with the hinge region, the N8 group points towards the solvent-exposed region, and the C7 cyano group occupies a small pocket.\",\n    \"Property_Analysis\": \"JNK3 inhibition often involves hydrogen bonding with the hinge region (Met149 in JNK3) via the N1 and N-NH of the C2 substituent, hydrophobic interactions in the ATP binding pocket, and interactions with the specificity pocket. The tert-pentylamino group provides hydrophobicity but its bulkiness might not be optimal. The cyano group is electron-withdrawing and could potentially form H-bonds or dipole interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large, sterically demanding tert-pentyl group at N8 might cause steric clashes or suboptimal hydrophobic interactions within the JNK3 active site, potentially limiting potency or selectivity. The cyano group at C7 might not be ideal for interactions in its corresponding pocket, possibly leading to weaker binding compared to other substituents or even unfavorable interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, we can explore modifications at the N8 and C7 positions. Replace the bulky tert-pentylamino group at N8 with a smaller, potentially more optimal hydrophobic group like isopropylamino, which might fit better into the pocket. Remove the C7 cyano group (replace with H), as small non-polar substituents or H are often well-tolerated or even preferred in this region for related kinase inhibitors, simplifying the structure and potentially removing unfavorable interactions.\",\n    \"Final_Target_Molecule\": \"CC(C)Nc1cncc2ncc(NCc3cccnc3)cc12\"\n  }\n]"
    },
    {
        "src_smiles": "O=C1SC(=Cc2ccc3cc(F)ccc3n2)C(=O)N1CCN1CCCCC1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a thiazolidinedione core acting as a central scaffold. It is substituted at the 5-position with a benzylidene linker (=CH-) attached to a 7-fluoroquinolin-6-yl moiety. The nitrogen atom of the thiazolidinedione ring is N-alkylated with a 2-(piperidin-1-yl)ethyl side chain.\",\n    \"Property_Analysis\": \"The molecule incorporates known pharmacophoric elements for kinase inhibition. The extended aromatic system (fluoroquinoline) likely interacts with the hydrophobic pocket near the ATP binding site of JNK3. The thiazolidinedione core can participate in hydrogen bonding. The basic piperidinoethyl side chain potentially forms salt bridges or hydrogen bonds with residues near the solvent-exposed region or hinge region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific substitution pattern and electronics of the 7-fluoroquinoline ring might not be optimal for binding affinity and selectivity towards JNK3. The fluorine atom's position might not provide the best interaction within the target pocket. Furthermore, the overall lipophilicity and planarity might need adjustment for improved potency or pharmacokinetic properties. The piperidine basicity and conformation might also be suboptimal for interaction.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, modifications will focus on the quinoline moiety, a key area for hydrophobic and potential hydrogen bond interactions. Replacing the 7-fluoroquinoline group with an indole derivative, specifically 5-methoxyindole, is proposed. Indole is a common motif in kinase inhibitors, and the 5-methoxy group can potentially form beneficial interactions within the JNK3 active site or modulate electronic properties favourably. The attachment point will be kept analogous (via the methylene linker at position 3 of the indole). The core thiazolidinedione and the piperidinoethyl side chain remain unchanged in this step.\",\n    \"Final_Target_Molecule\": \"COc1ccc2[nH]cc(C=C3SC(=O)N(CCN4CCCCC4)C3=O)c2c1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(NC3CCCNC3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an imidazo[4,5-b]pyridine core. An isopropyl group is attached at the N1 position of the imidazole ring. A piperidine ring is linked via an amino group at the C2 position of the pyridine ring. A 3-chloro-5-aminoaniline group is linked via an amino group at the C6 position of the pyridine ring.\",\n    \"Property_Analysis\": \"The imidazo[4,5-b]pyridine core serves as a scaffold common in kinase inhibitors. The substituents at C2 and C6 are crucial for interacting with the ATP binding site of JNK3. The C6 aniline derivative likely forms hydrogen bonds and hydrophobic interactions within the binding pocket, while the C2 piperidine interacts with another region. The N1-isopropyl group likely points towards the solvent-exposed region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 3-chloro-5-aminoaniline group at C6 might not provide optimal interactions for potent and selective JNK3 inhibition. The combination of the chloro and amino substituents, along with their positions, may lead to suboptimal binding affinity or potential off-target effects. The para-amino group could introduce polarity or metabolic liabilities not ideal for JNK3 inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, the C6 substituent will be modified. Replace the 3-chloro-5-aminoaniline group with a 3-fluoroaniline group. Fluorine is often beneficial for kinase inhibitor binding affinity and metabolic stability. Removing the para-amino group might reduce polarity and potential liabilities while maintaining or improving key interactions within the JNK3 active site.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(Nc3cccc(F)c3)nc(NC4CCCNC4)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(Nc4nccs4)c3)ncnc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a quinazoline core. Position 4 is substituted with a large, flexible aminomethylphenylaniline-thiazole group [NCc3cccc(Nc4nccs4)c3]. Position 8 bears a primary carboxamide group [NC(=O)]. The quinazoline acts as a potential hinge-binding motif, common in kinase inhibitors. The C4 substituent likely explores the ATP binding pocket or solvent-exposed region. The C8 amide can potentially form hydrogen bonds.\",\n    \"Property_Analysis\": \"Quinazoline derivatives are known scaffolds for various kinase inhibitors, including JNKs. The core nitrogen atoms (N1, N3) can form hydrogen bonds with the kinase hinge region. The C4 substituent's size and nature significantly influence potency and selectivity by interacting with different parts of the ATP pocket. The C8 amide might contribute to binding affinity or solubility.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large and flexible C4 substituent [NCc3cccc(Nc4nccs4)c3] may lead to an entropic penalty upon binding, reducing overall affinity. The specific aniline-thiazole moiety might not be optimal for specific interactions within the JNK3 active site compared to other known JNK3-targeting fragments. The methylene linker (-CH2-) between C4 and the phenyl ring might not provide the optimal geometry or interaction type (e.g., H-bonding) compared to a direct heteroatom linker like -NH- or -O-.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, replace the complex C4 substituent with a group known to confer potency in kinase inhibitors. Specifically, replace the aminomethyl linker and the downstream groups with a direct anilino linker (-NH-) attached to a para-fluorophenyl group. The -NH- linker can act as a hydrogen bond donor, potentially interacting with the kinase backbone, and the 4-fluorophenyl group is a common motif in kinase inhibitors, potentially forming favorable interactions in the hydrophobic pocket near the gatekeeper residue. The C8 amide is retained.\",\n    \"Final_Target_Molecule\": \"NC(=O)c1cccc2c(Nc3ccc(F)cc3)ncnc12\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(OC)c(C2=NOC(C(=O)Nc3cccc(C(C)=O)c3)C2)c1",
        "prop": "jnk",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central isoxazole core. One side is attached to a 2,4-dimethoxyphenyl ring. The other side is linked via an amide bond to a meta-acetylphenyl ring.\",\n  \"Property_Analysis\": \"The molecule contains typical pharmacophoric features for kinase inhibitors: aromatic rings for hydrophobic interactions/pi-stacking, an isoxazole ring as a potential hinge binder scaffold, and an amide linker providing hydrogen bonding capability. The dimethoxy groups are electron-donating, while the acetyl group is electron-withdrawing.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The meta-acetylphenyl group might not be optimal for JNK3 binding. The position and nature of the acetyl group might lead to suboptimal interactions within the ATP binding pocket, potentially limiting potency or introducing unfavorable steric clashes compared to substituents commonly found in potent JNK inhibitors (e.g., para-substituents, smaller polar groups).\",\n  \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the meta-acetylphenyl group will be replaced. A para-cyanophenyl group is chosen as a modification. Para-substitution is often favorable in kinase inhibitors, and the cyano group is a smaller, polar, electron-withdrawing group that can act as a hydrogen bond acceptor and potentially improve binding affinity within the JNK3 active site.\",\n  \"Final_Target_Molecule\": \"COc1ccc(OC)c(C2=NOC(C(=O)Nc3ccc(C#N)cc3)C2)c1\"\n}]"
    },
    {
        "src_smiles": "CC1CC(C)CN(S(=O)(=O)c2ccc(C(=O)NCc3ccco3)cc2)C1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central 4-sulfonylphenylamide core. Attached to the sulfonyl group is a 2,5-dimethylpiperidine ring. Attached to the amide nitrogen is a furfurylmethyl group.\",\n    \"Property_Analysis\": \"The molecule possesses features common in kinase inhibitors: a heterocyclic group (piperidine) likely interacting with hydrophobic pockets, a central scaffold (sulfonylphenylamide) capable of H-bonding interactions via amide NH/carbonyl O and sulfonyl O, and an appendage (furfuryl group) potentially occupying a solvent-exposed region or specific subpocket. Its JNK3 inhibitory potential depends on how well these features complement the JNK3 active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The furfuryl group might offer suboptimal interactions (hydrophobic, H-bonding, pi-stacking) within the relevant JNK3 subpocket compared to other substituents. Furan rings can also present metabolic stability liabilities. The 2,5-dimethylpiperidine ring's substitution pattern and stereochemistry (undefined in SMILES) may not be optimal for fitting the corresponding JNK3 pocket.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance JNK3 inhibition, the furfuryl group on the amide nitrogen will be replaced. A pyridinylmethyl group, specifically 3-pyridinylmethyl, is proposed. Pyridine offers potentially improved metabolic stability over furan and introduces a nitrogen atom capable of acting as an H-bond acceptor or participating in specific polar interactions within the kinase active site, which might improve binding affinity.\",\n    \"Final_Target_Molecule\": \"CC1CC(C)CN(S(=O)(=O)c2ccc(C(=O)NCc3cnccc3)cc2)C1\"\n  }\n]"
    },
    {
        "src_smiles": "COC(=O)c1ccc(-c2ccc(C=C3SC(=O)NC3=O)o2)c(O)c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a central phenyl ring substituted with a methyl ester (COC(=O)-) and a hydroxyl (-OH) group. This phenyl ring is linked to a furan ring. The furan ring is further substituted with an exocyclic double bond (=C) connected to a thiazolidinedione ring (SC(=O)NC=O). Key motifs include the ester, phenol, phenyl-furan core, and the thiazolidinedione heterocycle.\",\n    \"Property_Analysis\": \"The thiazolidinedione moiety is a known pharmacophore found in inhibitors of various enzymes, including kinases, potentially interacting with the ATP binding site. The phenyl-furan scaffold positions this group. The phenol and ester groups influence polarity, solubility, and potential hydrogen bonding interactions. The conjugated system involving the furan, double bond, and thiazolidinedione provides rigidity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methyl ester group is susceptible to hydrolysis by esterases in vivo, potentially limiting metabolic stability and duration of action. The phenol group is prone to phase II metabolism (glucuronidation/sulfation), leading to rapid clearance. The thiazolidinedione ring, while potentially active, can sometimes be associated with reactivity or toxicity issues. The overall lipophilicity and electronic distribution might not be optimal for potent and selective JNK3 binding.\",\n    \"Optimization_for_Source_Molecule\": \"To improve metabolic stability, the hydrolyzable methyl ester can be replaced with a more stable amide group (-C(=O)N). An amide retains hydrogen bonding potential similar to the ester carbonyl but is significantly more resistant to hydrolysis. This modification aims to enhance pharmacokinetic properties while potentially maintaining or improving binding affinity.\",\n    \"Final_Target_Molecule\": \"NC(=O)c1ccc(-c2ccc(C=C3SC(=O)NC3=O)o2)c(O)c1\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrimido[4,5-b]pyridin-4(3H)-one core. Key substituents include an N-methyl group on the pyrimidone nitrogen, a 2,4-difluorophenoxy group attached at position 6, and a piperidin-4-ol group linked via its nitrogen atom to position 2 of the pyrimidine ring.\",\n    \"Property_Analysis\": \"The molecule is evaluated for its c-Jun N-terminal kinase 3 (JNK3) inhibitory activity. This property depends on the molecule's ability to bind effectively to the ATP-binding site of JNK3, typically involving hydrogen bonds with the hinge region (e.g., Met111) and interactions with hydrophobic pockets and specific residues within the active site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 2,4-difluorophenoxy group, while occupying a hydrophobic pocket, might not establish optimal van der Waals contacts or could introduce unfavorable electronic interactions due to the fluorine atoms. The oxygen linker provides a specific geometry that might not be ideal for maximizing interactions. Furthermore, the piperidin-4-ol moiety's interaction profile in the solvent-exposed region might be suboptimal for potent JNK3 inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the 2,4-difluorophenoxy group is replaced with a 4-fluoroanilino group. This changes the linker from an ether (-O-) to an amine (-NH-), introducing a hydrogen bond donor which could form beneficial interactions with the protein backbone or nearby residues. The 4-fluorophenyl group is retained to occupy the hydrophobic pocket, potentially offering slightly different steric and electronic properties compared to the 2,4-difluorophenyl group.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(Nc2ccc(F)cc2)cc2cnc(N3CCC(O)C3)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "N#Cc1cc2cnc(NCc3ccccc3)nc2n(C2CCCC2)c1=O",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrido[2,3-d]pyrimidin-7-one core. Key substituents include a cyano group at C6, a benzylamine group attached via a methylene linker at C2, and a cyclopentyl group at N8.\",\n    \"Property_Analysis\": \"The pyrido[2,3-d]pyrimidin-7-one scaffold is a known hinge-binding motif in kinase inhibitors, mimicking the adenine base of ATP. The C2 and N8 substituents occupy hydrophobic pockets within the JNK3 active site. The cyano group likely contributes to electronic properties and potentially minor interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The cyclopentyl group at N8 might not provide optimal hydrophobic packing or interactions compared to other alkyl groups often found in potent JNK3 inhibitors (e.g., tert-butyl). The flexible benzylamine group at C2 might adopt conformations that are not ideal for binding affinity or could introduce metabolic liabilities.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, replace the N8-cyclopentyl group with a tert-butyl group, which is often associated with enhanced potency in JNK inhibitors due to better hydrophobic fit. Replace the C2-benzylamine moiety with a 4-methylaniline group (NH-Ar) to explore different interactions within the pocket, potentially increase rigidity, and align with common SAR for kinase inhibitors where anilines are directly attached.\",\n    \"Final_Target_Molecule\": \"N#Cc1cc2cnc(Nc3ccc(C)cc3)nc2n(C(C)(C)C)c1=O\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrazolo[3,4-d]pyrimidine core. Key substituents include: a 3-chloroanilino group at the C6 position, an isopropyl group at the N9 position, and an N-isopropyl-N-(2-hydroxyethyl)amino group [CC(C)N(CCO)] at the C2 position.\",\n    \"Property_Analysis\": \"The pyrazolo[3,4-d]pyrimidine core acts as a hinge-binder, common in kinase inhibitors. The 6-(3-chloroanilino) group likely occupies the hydrophobic pocket near the gatekeeper residue, contributing to binding affinity. The N9-isopropyl group likely interacts with a hydrophobic region or extends towards the solvent. The N2-substituent [CC(C)N(CCO)] projects towards the solvent-exposed region, potentially influencing solubility and offering interaction points (H-bond donor/acceptor), but its bulk and flexibility might not be optimal for JNK3 binding.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N2-substituent [CC(C)N(CCO)] is relatively large, conformationally flexible, and possesses multiple functional groups (amine, alcohol, isopropyl). This complexity may lead to suboptimal interactions within the JNK3 active site, potentially causing steric clashes, unfavorable desolvation penalties, or poor pharmacokinetic properties (e.g., metabolic liability at the ethanol moiety). Its contribution to specific JNK3 inhibition might be limited or even detrimental compared to simpler substituents.\",\n    \"Optimization_for_Source_Molecule\": \"Simplify the N2 position to potentially improve binding affinity, selectivity, and pharmacokinetic properties. A common optimization strategy for purine-like scaffolds is to remove or replace complex N2 substituents. Removing the entire N-isopropyl-N-(2-hydroxyethyl)amino group (replacing it with hydrogen) simplifies the structure significantly, eliminates potential steric hindrance and metabolic liabilities associated with this group, and focuses on the core interactions driven by the pyrazolo[3,4-d]pyrimidine scaffold and the C6-anilino group.\",\n    \"Final_Target_Molecule\": \"Clc1cccc(Nc2nc3c(ncn3C(C)C)n2)c1\"\n  }\n]"
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(Nc4ncccn4)c3)ncnc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, NC(=O)c1cccc2c(NCc3cccc(Nc4ncccn4)c3)ncnc12, features a quinazoline core substituted at position 4 with an aminomethyl linker attached to a meta-substituted phenyl ring. This phenyl ring bears a pyrimidin-4-ylamino group. Position 8 of the quinazoline core is substituted with a carboxamide group.\",\n    \"Property_Analysis\": \"The quinazoline scaffold, particularly when substituted at the 4-position, is a common motif in kinase inhibitors, often interacting with the hinge region of the ATP binding site. The pyrimidin-4-ylamino group is also a known hinge-binding element. The carboxamide at position 8 likely interacts with the solvent-exposed region or potentially the ribose pocket. The overall structure suggests potential interaction with the JNK3 ATP binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The specific combination and positioning of the groups might not be optimal for high JNK3 potency and/or selectivity. The carboxamide at the 8-position may introduce unfavorable steric or electronic interactions or suboptimal H-bonding. The pyrimidin-4-ylamino group, while a hinge binder, might not provide the best fit or interaction profile for JNK3 compared to other known motifs. The flexibility of the linker and the meta-substitution pattern could also be suboptimal.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, we propose two modifications: 1. Replace the 8-carboxamide group with a smaller, potentially more favorable cyano group (N#C), which can act as an H-bond acceptor and is often found in potent kinase inhibitors. 2. Replace the pyrimidin-4-ylamino hinge-binding group with an indazole group attached via its N1 position to the meta-position of the phenyl ring. Indazoles are known potent hinge binders in various kinases, potentially offering improved interactions within the JNK3 active site compared to the pyrimidineamine.\",\n    \"Final_Target_Molecule\": \"N#Cc1cccc2c(NCc3cccc(n4ncc5ccccc54)c3)ncnc12\"\n  }\n]"
    },
    {
        "src_smiles": "CNc1cc(N(CCCN(C)C)C(=O)Nc2c(Cl)cccc2Cl)ncn1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 2-(methylamino)pyrimidine core. Position 5 of the pyrimidine is substituted with a complex tertiary amine group. This nitrogen atom is bonded to both a 3-(dimethylamino)propyl chain (CCCN(C)C) and an N-(2,6-dichlorophenyl)carbamoyl group (C(=O)Nc2c(Cl)cccc2Cl). Key features include the hinge-binding motif (aminopyrimidine), a hydrophobic dichlorophenyl group, an amide linker, and a flexible, basic side chain.\",\n    \"Property_Analysis\": \"The 2-aminopyrimidine moiety is expected to interact with the JNK3 hinge region via hydrogen bonds. The dichlorophenyl group likely occupies a hydrophobic pocket within the ATP binding site. The amide group acts as a linker. The flexible and basic 3-(dimethylamino)propyl side chain likely extends towards the solvent-exposed region and might contribute to potency but could also negatively impact selectivity and pharmacokinetic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is likely the complex substituent at C5. The flexible, highly basic 3-(dimethylamino)propyl chain can lead to poor pharmacokinetic properties (e.g., high clearance, potential hERG liability, poor permeability) and potential off-target activity (lack of selectivity). The tertiary amine at C5 bearing both an alkyl chain and an acyl group is unusual and may present metabolic stability issues.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and overall druglike properties, simplification of the C5 substituent is proposed. The basic and flexible 3-(dimethylamino)propyl chain is removed. The N-(2,6-dichlorophenyl)carbamoyl group is attached directly to the C5 position via its nitrogen atom, forming a secondary amine linkage (NH) to the pyrimidine ring. This retains the key pharmacophoric elements (hinge binder, hydrophobic group, linker) while removing the problematic basic side chain and simplifying the substitution pattern, potentially improving metabolic stability, selectivity, and pharmacokinetic profile.\",\n    \"Final_Target_Molecule\": \"CNc1cc(NC(=O)Nc2c(Cl)cccc2Cl)ncn1\"\n  }\n]"
    },
    {
        "src_smiles": "CCCCNC(=O)Cc1c(OC)ccc2cc(Br)ccc12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a dibenzofuran core. Key substituents include a methoxy group at position 4, a bromine atom at position 8, and an N-butyl acetamide side chain attached at position 3.\",\n    \"Property_Analysis\": \"Dibenzofuran derivatives have shown potential as kinase inhibitors. The amide linkage can participate in hydrogen bonding within the kinase active site. The n-butyl chain provides lipophilicity. The bromine and methoxy groups influence electronic properties and steric interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The existing substituents (n-butyl, bromine, methoxy) may not provide optimal interactions with the JNK3 binding site. The flexibility of the n-butyl chain might lead to an entropic penalty upon binding. The bromine atom's position and electronic contribution might not be ideal for potency or selectivity. The methoxy group might introduce steric hindrance or unfavorable interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition: 1) Replace the flexible N-butyl group with a more rigid and potentially better-fitting N-cyclopropyl group to reduce conformational flexibility and explore hydrophobic interactions. 2) Replace the bromine atom at position 8 with a trifluoromethyl (CF3) group, a common modification in kinase inhibitors known to enhance binding affinity and metabolic stability. 3) Remove the methoxy group at position 4 to simplify the structure and potentially avoid unfavorable steric or electronic interactions, focusing interactions on the core and the CF3 group.\",\n    \"Final_Target_Molecule\": \"c1cc1NC(=O)Cc1cccc2cc(C(F)(F)F)ccc1o2\"\n  }\n]"
    },
    {
        "src_smiles": "C#Cc1cc(Oc2cnc(NCC(C)O)nc2N)c(C(C)C)cc1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, C#Cc1cc(Oc2cnc(NCC(C)O)nc2N)c(C(C)C)cc1OC, features a central 2-aminopyrimidine core linked via an ether bridge to a 1,3,4,5-tetrasubstituted benzene ring. The pyrimidine is further substituted with an (S)-1-amino-propan-2-ol side chain via the secondary amine. The benzene ring bears an ethynyl group, an isopropyl group, and a methoxy group.\",\n    \"Property_Analysis\": \"The 2-aminopyrimidine moiety is a common hinge-binding motif for kinases, likely forming hydrogen bonds with the JNK3 hinge region. The (S)-1-amino-propan-2-ol side chain likely extends towards the solvent-exposed region, potentially forming hydrogen bonds via its hydroxyl and amine groups. The substituted phenyl ring occupies a hydrophobic pocket, with the ethynyl, isopropyl, and methoxy groups contributing to van der Waals interactions and modulating physicochemical properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal ethynyl group can be metabolically labile (potential for oxidation or hydration) and may pose reactivity risks (e.g., potential for covalent modification or hERG inhibition). While providing linear rigidity, its contribution to JNK3 potency might not be optimal compared to alternative substituents occupying the same pocket.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the potentially labile and reactive terminal ethynyl group with a cyano group. The cyano group is a common bioisostere for terminal alkynes, maintaining linearity and similar electronic properties (electron-withdrawing) while being generally more metabolically stable and less prone to undesired reactivity. It can also act as a hydrogen bond acceptor, potentially improving interactions within the binding pocket.\",\n    \"Final_Target_Molecule\": \"COc1cc(C(C)C)c(Oc2cnc(NC[C@@H](C)O)nc2N)cc1C#N\"\n  }\n]"
    },
    {
        "src_smiles": "OC1CCCC(c2nccnc2Oc2ccc(Nc3ccccn3)cc2)C1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule contains a cyclohexanol ring attached to a pyrimidine core. The pyrimidine is linked via an ether oxygen to a para-substituted phenyl ring. This phenyl ring is connected through an amine linker (aniline-type) to a terminal pyridine ring.\",\n    \"Property_Analysis\": \"The pyrimidine core is a common scaffold for kinase inhibitors, likely interacting with the hinge region of JNK3. The cyclohexanol group and the substituted phenyl-ether-aniline-pyridine moiety occupy different sub-pockets of the ATP binding site, determining potency and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal pyridine group, connected via the aniline linkage, might not establish optimal interactions within the JNK3 active site for maximum potency. Furthermore, selectivity over other kinases, particularly JNK1 and JNK2, might be insufficient with this specific substitution pattern.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance JNK3 inhibition, the terminal pyridine ring can be replaced with a different heterocycle known to favor JNK3 binding. Replacing the pyridine with a 1H-pyrazol-3-yl group, connected via the same amine linker, can introduce different hydrogen bonding patterns (NH donor from pyrazole) and shape complementarity, potentially improving interactions with key residues in the JNK3 active site.\",\n    \"Final_Target_Molecule\": \"OC1CCCC(c1nccnc1Oc1ccc(Nc2cn[nH]c2)cc1)C1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)C(CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule is a 2,6,9-trisubstituted purine derivative. Key features include: 1) An N9-isopropyl group. 2) A C6-(ortho-hydroxybenzyl)amino substituent. 3) A C2-(1-hydroxy-3-methylbutan-2-yl)amino substituent. The purine core acts as a scaffold, with substituents modulating interactions within the kinase active site.\",\n    \"Property_Analysis\": \"The molecule contains typical pharmacophores for kinase inhibition, particularly the purine scaffold (hinge binding potential) and substituted amino groups at C2 and C6 interacting with different pockets of the ATP binding site. The N9-isopropyl likely occupies a hydrophobic pocket. The C6 benzylamino group and the C2 amino alcohol group contribute to potency and potentially selectivity via hydrogen bonding and hydrophobic interactions.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The C2 (1-hydroxy-3-methylbutan-2-yl)amino substituent possesses significant flexibility and multiple potential interaction points (NH, OH, isopropyl), which may not lead to optimal binding affinity or could introduce metabolic liabilities. The specific stereochemistry (if racemic) might lead to mixed activity. The ortho-position of the hydroxyl group on the C6 benzyl moiety might not be optimal for forming strong hydrogen bonds compared to meta or para positions often favoured in JNK inhibitors.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition: 1) Replace the flexible and complex C2 amino alcohol substituent with a more conformationally restricted and commonly favorable group for kinase inhibitors, such as a morpholino group, known to improve solubility and potency. 2) Modify the C6 substituent by repositioning the hydroxyl group on the benzyl ring from the ortho to the meta position, which is often found to enhance binding affinity in similar kinase inhibitor scaffolds by optimizing hydrogen bonding interactions.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(NCc3cccc(O)c3)nc(N4CCOCC4)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an aminopyrazole fused to an indole-like ring system (imidazo[1,2-a]pyridine derivative core). This core is substituted at the phenyl ring, which acts as a linker to a urea moiety (-NHC(=O)NH-). The urea connects to a terminal meta-fluorophenyl group.\",\n    \"Property_Analysis\": \"The aminopyrazole core is a known hinge-binding motif for kinases, potentially interacting with the JNK3 hinge region. The urea group can form multiple hydrogen bonds within the ATP-binding site. The extended structure with the phenyl linker and terminal fluorophenyl group likely occupies hydrophobic pockets and contributes to overall binding affinity and potentially selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The urea linkage can be metabolically labile and may lead to poor pharmacokinetic properties. The flexibility of the urea linker might not be optimal for rigid binding. The specific substitution pattern and the terminal meta-fluorophenyl group might not provide ideal interactions (hydrophobic, pi-stacking, hydrogen bonding) within the JNK3 active site for maximum potency or selectivity against other kinases.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the potentially labile and flexible urea linker (-NHC(=O)NH-) with a more stable and potentially conformationally defined amide linker (-C(=O)NH- or -NHC(=O)-). This involves connecting the terminal fluorophenyl group via an amide directly to the central phenyl ring, specifically changing the aniline linkage to a benzamide or vice-versa. Let's modify it to a benzamide structure: Replace the -NHC(=O)NH- linkage originating from the central phenyl's para-position aniline nitrogen with a -C(=O)NH- linkage directly attached to the central phenyl's para-position carbon.\",\n    \"Final_Target_Molecule\": \"Nc1n[nH]c2cccc(-c3ccc(C(=O)Nc4cccc(F)c4)cc3)c12\"\n  }\n]"
    },
    {
        "src_smiles": "CCN(CC)CCn1c(NC(=O)c2ccc(C)cc2)nc2ccccc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCN(CC)CCn1c(NC(=O)c2ccc(C)cc2)nc2ccccc21, is a substituted benzimidazole. It features a benzimidazole core fused to a benzene ring. One nitrogen of the imidazole ring is substituted with a diethylaminoethyl group (CCN(CC)CC-). The other position on the imidazole ring (position 2) bears an amino group which forms an amide linkage (-NHC(=O)-) with a p-tolyl group (c2ccc(C)cc2).\",\n    \"Property_Analysis\": \"Benzimidazole derivatives are known scaffolds for various kinase inhibitors, including JNK inhibitors. The amide linkage and the aromatic substituent (p-tolyl) likely interact with the ATP binding site of JNK3, potentially forming hydrogen bonds with the hinge region and hydrophobic interactions. The diethylaminoethyl side chain may contribute to solubility and potentially interact with the solvent-exposed region or specific pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The p-tolyl group provides hydrophobic interaction but might not be optimal for potency or selectivity towards JNK3. Its interaction might be relatively weak compared to groups capable of forming stronger hydrogen bonds or more specific hydrophobic contacts within the JNK3 active site. The flexibility of the diethylaminoethyl chain might lead to an entropic penalty upon binding or allow non-specific interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially enhance JNK3 inhibition, the p-tolyl group can be replaced with a moiety that offers improved interactions within the ATP binding pocket. Substituting the methyl group with electron-withdrawing groups like fluorine or chlorine, or replacing the entire phenyl ring with heterocyclic systems (e.g., pyridine) known to interact favourably with kinase active sites, is a common strategy. Let's replace the p-tolyl group with a 3-fluorophenyl group. Fluorine substitution can modulate electronic properties and potentially form specific interactions (e.g., orthogonal multipolar C-F\u00b7\u00b7\u00b7C=O interactions) or improve metabolic stability without significantly increasing size.\",\n    \"Final_Target_Molecule\": \"CCN(CC)CCn1c(NC(=O)c2cccc(F)c2)nc2ccccc21\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccccc3)nc(I)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a pyrazolo[3,4-d]pyrimidine core. It is substituted with an isopropyl group at the N1 position of the pyrazole ring, a benzylamino group at the C4 position of the pyrimidine ring, and an iodine atom at the C6 position of the pyrimidine ring.\",\n    \"Property_Analysis\": \"The pyrazolo[3,4-d]pyrimidine scaffold is a known hinge-binding motif for various kinases, including JNK3. The N1-isopropyl group likely occupies a hydrophobic pocket. The C4-benzylamino group extends towards the solvent-exposed region or interacts with residues near the ATP binding site entrance. The C6-iodine atom occupies a specific pocket, potentially contributing to affinity but also impacting selectivity and metabolic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The C6-Iodo substituent, while potentially contributing to binding affinity through halogen bonding or hydrophobic interactions, might not be optimal for JNK3 inhibition. Large halogens can sometimes lead to metabolic liabilities (dehalogenation) or reduced selectivity against other kinases. Its size and electronic properties might not be ideal for the specific subpocket within the JNK3 active site compared to alternative substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, selectivity, and metabolic stability, the C6-Iodo group will be replaced. Replacing iodine with a smaller group capable of forming specific interactions, such as hydrogen bonds, is a common optimization strategy for this scaffold. A methylamino group (-NHCH3) is proposed, as amino groups at this position are often favorable for kinase inhibition, potentially forming hydrogen bonds with the protein backbone or side chains, and it's smaller and metabolically distinct from iodine.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(NCc3ccccc3)nc(NC)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(N(C)c3ccc(F)c(Cl)c3)c2cc1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, COc1cc2ncnc(N(C)c3ccc(F)c(Cl)c3)c2cc1OC, features a quinazoline core substituted at C4 with an N-methylanilino group. The aniline ring is further substituted with chlorine at the meta-position and fluorine at the para-position relative to the nitrogen attachment. The quinazoline ring itself is substituted with two methoxy groups at positions 6 and 7.\",\n    \"Property_Analysis\": \"The 4-anilinoquinazoline scaffold is a well-known pharmacophore for kinase inhibition, frequently targeting the ATP-binding site. The specific substitutions (dimethoxy on quinazoline, N-methyl, 3-chloro-4-fluoro on aniline) modulate potency, selectivity (including JNK3 vs other kinases), solubility, and metabolic stability. The N-methyl group and the halogen pattern on the aniline ring significantly influence interactions within the kinase hinge region and hydrophobic pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-methyl group might introduce steric hindrance or prevent a potentially crucial hydrogen bond interaction with the kinase hinge region backbone, which is often observed for potent inhibitors with secondary amine linkers (N-H). This could limit JNK3 binding affinity. Furthermore, the specific 3-Cl, 4-F pattern, while common, might not be optimal for JNK3 selectivity or potency compared to other substitution patterns or replacement groups.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the primary optimization strategy is to remove the methyl group from the aniline nitrogen. Replacing the tertiary amine (N-Me) with a secondary amine (N-H) could allow for a direct hydrogen bond donation to the hinge region of JNK3, a common interaction motif that often enhances binding affinity. This modification maintains the core scaffold and the key aniline substitutions while probing a critical interaction point.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2c(Nc3ccc4c(c3)OCO4)ncnc2c(OC)c1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, SMILES: COc1cc2c(Nc3ccc4c(c3)OCO4)ncnc2c(OC)c1OC, is a 4-anilinoquinazoline derivative. The quinazoline core is substituted with three methoxy groups at positions 6, 7, and 8. The aniline moiety at position 4 is derived from 3,4-methylenedioxyaniline.\",\n    \"Property_Analysis\": \"The 4-anilinoquinazoline scaffold is a well-known pharmacophore for kinase inhibition, targeting the ATP binding site. The specific substituents dictate potency and selectivity. The trimethoxy substitution pattern on the quinazoline and the methylenedioxy group on the aniline ring contribute to the overall electronic and steric profile, influencing binding affinity to JNK3 and potentially other kinases.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 3,4-methylenedioxy substitution on the aniline ring might not provide optimal interactions within the JNK3 ATP binding pocket. This group can also be metabolically labile (potential P450 inhibition or reactive metabolite formation). The overall combination of substituents might lack specific features required for high JNK3 potency and selectivity over other kinases. The multiple methoxy groups might also contribute to poor solubility or metabolic concerns.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially address metabolic concerns, the 3,4-methylenedioxyaniline moiety will be replaced. A common strategy to enhance JNK3 affinity and improve physicochemical properties involves introducing polar groups or groups capable of specific hydrogen bonding in the solvent-exposed region. Replacing the methylenedioxyaniline with 4-morpholinoaniline introduces a morpholine group, which can improve solubility, metabolic stability, and potentially engage in favorable interactions within or near the JNK3 active site.\",\n    \"Final_Target_Molecule\": \"COc1cc2c(Nc3ccc(N4CCOCC4)cc3)ncnc2c(OC)c1OC\"\n  }\n]"
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21, features a 1-Methyl-pyrazolo[1,5-a]pyrimidin-7-one core scaffold, which is known to interact with kinase hinge regions. Key substituents include: a 2,4-difluorophenoxy group at C6, likely interacting with the hydrophobic pocket near the gatekeeper residue; and a 3-hydroxypiperidin-1-yl group at C2, extending towards the solvent-exposed region.\",\n    \"Property_Analysis\": \"The molecule incorporates features typical of ATP-competitive kinase inhibitors. The pyrazolo[1,5-a]pyrimidine core can form hydrogen bonds with the kinase hinge. The difluorophenoxy group engages hydrophobic interactions. The C2 substituent interacts with the solvent-interface region. These elements suggest potential JNK3 inhibitory activity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 3-hydroxypiperidine group at the C2 position might not be optimal for JNK3 binding. Its size, conformation, and the specific hydrogen bonding vector provided by the hydroxyl group may lead to suboptimal interactions or steric clashes within the JNK3 active site's solvent-exposed region, limiting potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"Optimization focuses on modifying the C2 substituent to enhance interactions within the JNK3 active site, potentially improving potency and selectivity. The 3-hydroxypiperidine group is replaced with a morpholine ring. Morpholine is structurally related but replaces the CH(OH) unit with an oxygen ether linkage, altering hydrophilicity, hydrogen bonding capacity (acceptor only), and conformational profile. This modification aims for a better fit and interaction pattern in the JNK3 solvent-exposed region.\",\n    \"Final_Target_Molecule\": \"Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCOCC3)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "C=CCn1c(SCC(=O)NCc2ccco2)nc2sc(C)c(C)c2c1=O",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a complex heterocyclic core: 6,7-dimethyl-3-(prop-2-en-1-yl)-4H-thieno[3,2-e]thiazolo[4,5-b]pyridin-4-one. Key substituents include an allyl group at the N3 position of the thiazolopyridinone system and a thioether-linked N-furfurylacetamide group [SCC(=O)NCc2ccco2] at the C2 position.\",\n    \"Property_Analysis\": \"The core structure contains potential hydrogen bond acceptors (carbonyl oxygen, pyridine nitrogen, thiazole nitrogen) and hydrophobic regions (dimethylthiophene). The C2 side chain introduces additional hydrogen bond donors/acceptors (amide NH and C=O, furan oxygen) and a flexible linker (thioether, methylenes). These features provide potential interaction points within the JNK3 ATP binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N3-allyl group is small and primarily hydrophobic, potentially offering suboptimal interactions. The terminal furan ring in the C2 side chain has limited interaction potential (hydrophobic surface, one H-bond acceptor) compared to more commonly employed groups like substituted phenyl rings in potent kinase inhibitors. The overall flexibility of the C2 side chain might also hinder optimal binding conformation.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the terminal furan ring on the C2 side chain will be replaced. A 4-fluorophenyl group is proposed instead of the furfuryl group. This modification increases hydrophobic interactions, introduces potential halogen bonding via fluorine, and aligns with common SAR strategies for kinase inhibitors where substituted phenyl rings often improve potency by accessing specific subpockets.\",\n    \"Final_Target_Molecule\": \"C=CCn1c(SCC(=O)NCc2ccc(F)cc2)nc3sc(C)c(C)c3c1=O\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3ccc(C(F)(F)F)cc3)c2c(OC)c1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, COc1cc2ncnc(Nc3ccc(C(F)(F)F)cc3)c2c(OC)c1OC, features a quinazoline core substituted at the 4-position with a 4-(trifluoromethyl)aniline group and at positions 5, 6, and 7 with methoxy groups. The quinazoline core likely acts as a hinge binder common in kinase inhibitors. The aniline moiety extends into a hydrophobic pocket, and the trifluoromethyl group significantly increases lipophilicity and provides a potential interaction point. The trimethoxy substitution pattern on the quinazoline ring further contributes to lipophilicity and influences the overall shape and electronic properties.\",\n    \"Property_Analysis\": \"JNK3 (c-Jun N-terminal kinase 3) is a serine/threonine kinase implicated in neuronal apoptosis. Inhibitors typically target the ATP-binding site. Key interactions often involve hydrogen bonds with the hinge region (e.g., via quinazoline nitrogens N1/N3) and hydrophobic interactions within the pocket adjacent to the hinge. The source molecule's quinazoline scaffold and substituted aniline are consistent with known ATP-competitive kinase inhibitor pharmacophores.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The source molecule possesses high lipophilicity due to the three methoxy groups and the trifluoromethyl group, which could lead to poor pharmacokinetic properties (e.g., low solubility, high plasma protein binding) and potential off-target kinase activity (poor selectivity). The bulky methoxy groups might cause steric hindrance or not be optimally positioned for potent interactions within the JNK3 active site. The specific electron-withdrawing nature of the CF3 group might not be ideal for optimal potency or selectivity towards JNK3 compared to other substituents.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially drug-like properties, modifications focused on reducing lipophilicity and enhancing specific interactions are proposed. Replacing the highly lipophilic and electron-withdrawing 4-trifluoromethylphenyl group with a 4-morpholinophenyl group can improve solubility and introduce favorable interactions. Morpholine is a common motif in kinase inhibitors, often improving physicochemical properties and potentially interacting with polar residues or water molecules in the binding site. The trimethoxy pattern on the quinazoline core is retained initially, but could be further optimized (e.g., replacing methoxy with hydroxyl or smaller groups) in subsequent steps if needed.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3ccc(N4CCOCC4)cc3)c2c(OC)c1OC\"\n  }\n]"
    },
    {
        "src_smiles": "OC1CCC(Nc2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 2,4,6-trisubstituted pyrimidine core. Substituents include: a 4-(hydroxycyclohexyl)amino group, a 2-(phenethylamino)methyl group, and a 6-(pyridin-2-yl) group. Key motifs are the pyrimidine (potential hinge binder), cyclohexanol (potential H-bond donor/pocket filler), secondary amine linker, phenethyl group (hydrophobic interactions), and pyridyl group (potential interactions in solvent-exposed region).\",\n    \"Property_Analysis\": \"The pyrimidine core with flanking nitrogen-containing groups is a common scaffold for kinase inhibitors, likely interacting with the ATP binding site hinge region. The phenethyl group can occupy a hydrophobic pocket. The cyclohexanol group offers potential for hydrogen bonding and van der Waals interactions in another pocket. The pyridyl group may contribute to binding affinity and influence physicochemical properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The secondary alcohol on the cyclohexane ring might not be optimally positioned for hydrogen bonding interactions within the JNK3 active site, or it could introduce suboptimal physicochemical properties (e.g., metabolic liability). The flexibility of the cyclohexyl ring and the phenethyl linker could lead to an entropic penalty upon binding. The overall combination of substituents may not provide maximum affinity or selectivity for JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the hydroxycyclohexylamino group with a morpholino group. Morpholine is a privileged structure in medicinal chemistry, often improving metabolic stability and aqueous solubility compared to cyclohexanol derivatives. It maintains a similar size profile and offers a hydrogen bond acceptor (oxygen) and retains the amine linker to the pyrimidine core, potentially leading to improved interactions within the binding pocket and better overall drug-like properties.\",\n    \"Final_Target_Molecule\": \"O1CCN(c2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CCOc1ccc(CC(=O)Nc2c(C(N)=O)oc3ccc(Br)cc23)cc1OCC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 2-amidobenzofuran-3-carboxamide core. The benzofuran ring is substituted with a bromine atom at position 5. The amide nitrogen is linked to a benzyl group, which is further substituted with two ethoxy groups at the para positions relative to the methylene linker.\",\n    \"Property_Analysis\": \"The amide and carboxamide groups are potential hydrogen bond donors/acceptors crucial for kinase hinge binding. The benzofuran acts as a scaffold. The large bis-ethoxybenzyl group occupies a hydrophobic pocket, potentially the ATP binding site. The bromine atom contributes to lipophilicity and might form halogen bonds or influence electronic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky bis-ethoxybenzyl group might lead to steric hindrance or suboptimal fit within the JNK3 active site. High lipophilicity due to ethoxy groups and bromine could negatively impact solubility and pharmacokinetic properties. The bromine atom's contribution might not be optimal for potency or selectivity against JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition and potentially pharmacokinetic properties, the bis-ethoxybenzyl group can be replaced with a smaller, less lipophilic moiety known to interact favorably with kinase hydrophobic pockets, such as a 4-fluorobenzyl group. This reduces size and lipophilicity while introducing fluorine, often beneficial for binding. Additionally, removing the bromine atom simplifies the structure and reduces lipophilicity.\",\n    \"Final_Target_Molecule\": \"O=C(N)c1oc2ccccc2c1NC(=O)Cc1ccc(F)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CN(C)Cc1ccn2c(-c3ccnc(S(C)(=O)=O)n3)c(-c3ccc(F)cc3)nc2c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an imidazo[1,2-a]pyridine core. Key substituents include a dimethylaminomethyl group on the pyridine part, a 4-fluorophenyl group on the imidazole part, and a pyridine ring bearing a methylsulfonyl group also attached to the imidazole part.\",\n    \"Property_Analysis\": \"The imidazo[1,2-a]pyridine scaffold is common in kinase inhibitors. The 4-fluorophenyl group likely occupies a hydrophobic pocket. The methylsulfonylpyridine group potentially interacts with the hinge region or solvent-exposed areas via hydrogen bonding or polar interactions. The dimethylaminomethyl group may influence solubility and interact with the solvent front.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylsulfonyl group (S(C)(=O)=O) might not provide optimal interactions (e.g., hydrogen bonding strength or directionality) within the JNK3 active site compared to other potential hydrogen bond donors/acceptors. Its bulk and electronic properties might limit potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, replace the methylsulfonyl group with a methylcarboxamide group (C(=O)NC). Amides are often effective hydrogen bond donors/acceptors in kinase inhibitors and can provide different spatial and electronic interactions compared to sulfonyl groups, potentially leading to enhanced binding affinity and potency towards JNK3.\",\n    \"Final_Target_Molecule\": \"CNC(=O)c1ccnc(-c2c3nc(cc(CN(C)C)c3)ccn2-c2ccc(F)cc2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "COCCn1c(=O)c(-c2ccc(OC)cc2)nc2cnc(OCc3ccccc3)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule possesses a pyrimido[4,5-d]pyrimidine core scaffold. Key substituents include a methoxyethyl group at the N1 position (COCCn1), a carbonyl group at C4 (=O), a 4-methoxyphenyl group at the C6 position (-c2ccc(OC)cc2), and a benzyloxymethyl group at the C2 position of the second pyrimidine ring (cnc(OCc3ccccc3)nc2).\",\n    \"Property_Analysis\": \"The pyrimido[4,5-d]pyrimidine core likely acts as a hinge-binding motif common in kinase inhibitors, potentially forming hydrogen bonds with the JNK3 hinge region via nitrogen atoms and the carbonyl oxygen. The 4-methoxyphenyl and benzyloxymethyl substituents occupy hydrophobic pockets within or near the ATP binding site, contributing to binding affinity. The N1-methoxyethyl group likely extends towards the solvent or ribose pocket region.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The flexibility of the benzyloxymethyl linker (-O-CH2-) at the C2 position might lead to an entropic penalty upon binding and potentially suboptimal interactions within the target pocket. The 4-methoxyphenyl group might not be the optimal substituent for maximizing potency or achieving selectivity for JNK3 over other kinases. The N1-methoxyethyl group could also be suboptimal for potency and ADME properties.\",\n    \"Optimization_for_Source_Molecule\": \"To improve JNK3 inhibition, we can modify the substituents. Replace the flexible benzyloxymethyl group at C2 with a more rigid or polar group capable of specific interactions, such as a morpholinomethyl group (-CH2-N(CH2CH2)2O), which can form hydrogen bonds and has a defined conformation. Modify the C6 substituent by replacing the 4-methoxyphenyl group with a 4-fluorophenyl group (-c1ccc(F)cc1) to potentially enhance binding affinity through halogen interactions or improved electronic properties while maintaining similar size.\",\n    \"Final_Target_Molecule\": \"COCCn1c(=O)c(-c2ccc(F)cc2)nc2cnc(CN3CCOCC3)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "Cc1ncc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)s1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central phenyl ring substituted at the meta position with an amide linker and a sec-butylamino group. The amide nitrogen is connected to a methylthiazole carboxamide moiety. The sec-butylamino nitrogen is linked to a 4-amino-pyrrolo[3,2-c]pyrimidine-7-carboxamide system, which likely acts as the hinge-binding element.\",\n    \"Property_Analysis\": \"The molecule incorporates known pharmacophoric elements for kinase inhibition, particularly the pyrimidine-based heterocycle often targets the hinge region of kinases like JNK3. The amide linker positions the thiazole group towards a solvent-exposed region or another pocket. The sec-butyl linker introduces chirality and specific spatial constraints.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The sec-butylamino linker (-CH(CH3)NH-) introduces a chiral center and potentially non-optimal flexibility or steric bulk, which might hinder ideal interaction with the JNK3 active site compared to a simpler linker. The orientation provided by this specific linker might not maximize binding affinity or could introduce unfavorable interactions.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve binding affinity and reduce complexity, the sec-butylamino linker can be simplified. Replacing the -CH(CH3)NH- linker with a direct amino (-NH-) linker maintains the connection to the hinge-binding motif while removing the chiral center and potentially allowing a more favorable binding pose within the ATP pocket. This modification simplifies synthesis and removes potential metabolic liabilities associated with the benzylic-like carbon.\",\n    \"Final_Target_Molecule\": \"Cc1ncc(C(=O)Nc2cccc(Nc3ncnc4c(C(N)=O)cccc34)c2)s1\"\n  }\n]"
    },
    {
        "src_smiles": "NC1=NC(CF)(c2cc(Oc3ncccc3F)ccc2F)CC(C(F)(F)F)O1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central dihydrooxazole (oxazoline) ring substituted with an amino group, a trifluoromethyl group (C(F)(F)F), and a monofluoromethyl group (CF). This core is further substituted with a complex aryl group: a fluorophenyl ring linked via the monofluoromethyl carbon, which is meta-substituted with a fluoro-pyridyl ether group and ortho-substituted (relative to the ether) with a fluorine atom.\",\n    \"Property_Analysis\": \"The molecule contains structural motifs common in kinase inhibitors. The amino-oxazoline core likely acts as a hinge-binder, interacting with the kinase ATP binding site backbone via hydrogen bonds. The trifluoromethyl and monofluoromethyl groups influence lipophilicity, metabolic stability, and potentially interact with specific sub-pockets. The substituted fluorophenyl-pyridyl ether moiety occupies the hydrophobic region/selectivity pocket, significantly impacting potency, selectivity (against JNK isoforms and other kinases), and pharmacokinetic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The bulky and potentially metabolically labile fluoro-pyridyl ether group might limit oral bioavailability, increase clearance, or reduce binding affinity compared to smaller, more optimized substituents. The monofluoromethyl (CF) group is less common than trifluoromethyl (CF3) in optimized kinase inhibitors and might offer suboptimal hydrophobic interactions or metabolic stability. The overall combination might lack sufficient potency or selectivity specifically for JNK3 over other kinases like JNK1/2 or p38.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition and drug-like properties, we propose replacing the monofluoromethyl (CF) group with a trifluoromethyl (CF3) group, known to enhance metabolic stability and fill hydrophobic pockets effectively. We will also replace the complex meta-fluoro-pyridyl ether substituent on the phenyl ring with a smaller, potentially more favorable cyano (-C#N) group at the same meta position, aiming to improve binding affinity, simplify the structure, and potentially enhance pharmacokinetic properties while maintaining the ortho-fluorine.\",\n    \"Final_Target_Molecule\": \"NC1=NC(C(F)(F)F)(c2cc(C#N)ccc2F)CC(C(F)(F)F)O1\"\n  }\n]"
    },
    {
        "src_smiles": "COCCNC1CCC(Nc2cc(-c3nc(NCC4CCOCC4)ccc3Cl)c(Cl)cn2)CC1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central 5-amino-6-chloropyrimidine core. The C5 amino group is substituted with a 1-(2-methoxyethyl)piperidin-4-yl group. The C4 position of the pyrimidine is substituted with a 4-chloro-2-(morpholinomethyl)phenyl group. Key motifs include: aminopyrimidine (potential hinge binder), piperidine linker, N-methoxyethyl side chain (solvent interaction), 4-chloro-2-(morpholinomethyl)phenyl group (hydrophobic pocket interactions). Assuming the SMILES represents: COCCN1CCC(Nc2cc(-c3ccc(Cl)c(CN4CCOCC4)c3)c(Cl)cn2)CC1.\",\n    \"Property_Analysis\": \"The aminopyrimidine core likely interacts with the JNK3 hinge region via hydrogen bonds. The 4-chloro-2-(morpholinomethyl)phenyl group occupies a hydrophobic pocket, with the chlorine contributing to hydrophobic binding and the morpholinomethyl group potentially forming H-bonds or polar interactions. The N-methoxyethyl piperidine substituent extends towards the solvent-exposed region, influencing solubility and potentially interacting with surface residues.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-methoxyethyl group on the piperidine nitrogen is flexible and may not provide optimal interactions within the solvent-exposed region for maximizing JNK3 inhibition. Its specific polarity and H-bonding capability (ether oxygen as acceptor only) might be suboptimal compared to other functional groups.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition, the N-methoxyethyl group on the piperidine can be replaced to explore different interactions in the solvent-exposed region. Replacing it with an N-acetyl group introduces an amide moiety, offering both hydrogen bond accepting (carbonyl) and donating (if N-H tautomerism/protonation occurs, though unlikely here) potential along with potential conformational restriction compared to the ether chain. This modification aims to enhance interactions with surface residues or water structure, potentially improving binding affinity.\",\n    \"Final_Target_Molecule\": \"CC(=O)N1CCC(Nc2cc(-c3ccc(Cl)c(CN4CCOCC4)c3)c(Cl)cn2)CC1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccc(-c4ccccc4)cc3)nc(N(CCO)CCO)nc21",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a purine scaffold. Key substituents include: an isopropyl group at N1, a diethanolamine group attached via nitrogen at C6, and a 4-phenylbenzylamine group attached via the amine nitrogen at C8.\",\n    \"Property_Analysis\": \"The purine core likely acts as a hinge-binding motif, common for kinase inhibitors. The N1-isopropyl group occupies a hydrophobic pocket. The C8-(4-phenylbenzylamine) substituent likely explores a larger hydrophobic region. The C6-diethanolamine group provides H-bond acceptors (O, N) and potentially donors (OH), contributing to solubility and potentially interacting with solvent-exposed regions or specific polar residues.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The diethanolamine group at C6 introduces significant flexibility and polarity. The two hydroxyl groups might lead to unfavorable interactions, metabolic instability, or poor cell permeability. This high flexibility might also result in an entropic penalty upon binding, potentially limiting JNK3 inhibitory potency or selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To address the limitations of the C6-diethanolamine group, replace it with a conformationally constrained and potentially less polar cyclic amine, such as morpholine. Morpholine retains a nitrogen for attachment and an oxygen atom as a hydrogen bond acceptor but reduces flexibility and removes the potentially problematic hydroxyl groups, aiming for improved binding affinity, selectivity, and pharmacokinetic properties.\",\n    \"Final_Target_Molecule\": \"CC(C)n1cnc2c(NCc3ccc(-c4ccccc4)cc3)nc(N3CCOCC3)nc21\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3cc(Cl)ccc3Cl)c2cc1OCCCCCC(=O)NO",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule has a quinazoline core. Key substituents include: a methoxy group at position 6, a 3,5-dichloroanilino group (relative to attachment point) at position 4, and a long alkoxy chain terminating in a hydroxamic acid group (-O(CH2)6C(=O)NHOH) at position 7.\",\n    \"Property_Analysis\": \"The quinazoline core with the 4-anilino substituent is a common scaffold for kinase inhibitors, likely interacting with the ATP binding site of JNK3. The nitrogen atoms in the quinazoline can form hydrogen bonds with the kinase hinge region, while the dichloroanilino group occupies a hydrophobic pocket. The C7 substituent extends towards the solvent region, and the hydroxamic acid might form additional interactions or affect solubility/PK.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The long, flexible C7 chain (O(CH2)6C(=O)NHOH) likely introduces significant conformational flexibility, potentially leading to an entropic penalty upon binding and reducing potency. Hydroxamic acids can also suffer from poor pharmacokinetic properties (metabolic instability, potential toxicity) and may not be optimal for JNK3 interaction compared to groups typically found in kinase inhibitors.\",\n    \"Optimization_for_Source_Molecule\": \"Simplify the C7 substituent to reduce flexibility and remove the potentially problematic hydroxamic acid group. Replace the -O(CH2)6C(=O)NHOH group with a smaller, less flexible group commonly found in quinazoline kinase inhibitors that may improve binding affinity or pharmacokinetic properties. A simple methoxy group is chosen for simplification and analogy with the C6 substituent, aiming to probe the SAR at this position.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3cc(Cl)ccc3Cl)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "CS(=O)(=O)Nc1ccc(-c2cnc3cccc(Nc4ncccc4Cl)c3c2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule consists of a central imidazo[1,2-a]pyridine scaffold. Position 2 is substituted with a 4-(methanesulfonamido)phenyl group. Position 7 bears a (4-chloropyridin-2-yl)amino group, which acts as the hinge-binding element.\",\n    \"Property_Analysis\": \"The (4-chloropyridin-2-yl)amino moiety is positioned to interact with the kinase hinge region via hydrogen bonds (NH donor, pyridine N acceptor). The 4-chloro substituent likely occupies a hydrophobic pocket. The imidazo[1,2-a]pyridine core serves as a rigid scaffold. The 4-(methanesulfonamido)phenyl group extends into another pocket, potentially interacting via the sulfonamide (H-bond donor/acceptor) and phenyl ring (hydrophobic interactions), contributing to overall binding affinity for JNK3.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methanesulfonamide group might have suboptimal interactions or could lead to poor pharmacokinetic properties (e.g., metabolic instability, low solubility). The overall binding affinity or selectivity for JNK3 over other kinases (like JNK1/2 or p38) might be improvable. The specific geometry imposed by the scaffold and linker might not be optimal for JNK3 inhibition.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve metabolic stability, potency, and lipophilic efficiency, replace the methanesulfonamide group with a cyclopropanesulfonamide group. The cyclopropyl group often enhances metabolic stability compared to a methyl group and can provide favorable hydrophobic interactions without significantly increasing molecular weight.\",\n    \"Final_Target_Molecule\": \"O=S(=O)(Nc1ccc(-c2cnc3cccc(Nc4ncccc4Cl)c3c2)cc1)C1CC1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC(=O)NO",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 4-(3-bromoanilino)quinazoline core. Key substitutions include a methoxy group at C7 (likely position based on typical numbering) and an O-linked propionyl hydroxamic acid side chain (`OCCC(=O)NO`) at C6 (likely position). The anilinoquinazoline scaffold is a known kinase inhibitor template, with the 3-bromoanilino group likely interacting with the hinge region. The hydroxamic acid moiety is a metal-chelating group.\",\n    \"Property_Analysis\": \"The 4-anilinoquinazoline scaffold suggests potential kinase inhibitory activity. The specific substitutions determine potency and selectivity. The 3-bromo substituent on the aniline ring often contributes to binding affinity in kinase active sites. The hydroxamic acid group's contribution to JNK3 inhibition is uncertain; while it can form interactions, it's not a typical pharmacophore for ATP-competitive JNK3 inhibitors and might introduce liabilities.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The primary limitation is the hydroxamic acid group (`C(=O)NO`). It is metabolically labile (prone to hydrolysis/reduction) and can cause off-target effects via metal chelation or reactivity, potentially leading to toxicity. This functional group may not be optimal for specific interactions within the JNK3 active site compared to more common substituents found in potent JNK3 inhibitors. The linker length (`OCCC`) might also not be ideal for positioning.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the metabolically labile and potentially problematic hydroxamic acid group with a more stable functional group commonly found in kinase inhibitors. Replacing `-C(=O)NO` with a simple tertiary amide like dimethylamide (`-C(=O)N(C)C`) removes the hydroxamic acid liability while retaining a polar group capable of hydrogen bonding. This modification aims to improve metabolic stability and potentially enhance binding interactions or pharmacokinetic properties without drastically altering the core structure.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC(=O)N(C)C\"\n  }\n]"
    },
    {
        "src_smiles": "CC(=O)NC(C)c1ccc(OC2CCN(c3ccnc(N4CCCC(F)(F)C4)n3)C2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features an N-acetyl aminopyrazine core structure. Key components include: 1) An N-acetyl group attached to a chiral alpha-methyl benzyl amine. 2) A phenoxy linker connecting the benzyl group to a piperidine ring. 3) The piperidine ring N-substituted with an aminopyrazine moiety. 4) The aminopyrazine ring further substituted with a 4,4-difluoropiperidine group.\",\n    \"Property_Analysis\": \"The aminopyrazine core likely acts as a hinge binder for the JNK3 ATP binding site. The piperidine linker positions the phenoxyacetamide group towards the solvent front or specific JNK3 subpockets. The difluoropiperidine likely occupies a solvent-exposed region, potentially influencing solubility and metabolic stability. The N-acetyl-alpha-methylbenzyl group explores interactions within the kinase pocket, potentially influencing potency and selectivity.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-acetyl group might offer limited potency or suboptimal interactions within the JNK3 binding site. Its flexibility and potential metabolic lability could be drawbacks. The specific interactions mediated by the alpha-methyl group might not be optimal for maximizing affinity or selectivity for JNK3.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, replace the flexible and potentially labile N-acetyl group (CC(=O)-) with a more rigid and potentially metabolically stable cyclopropanecarbonyl group (C1CC1C(=O)-). This modification aims to improve binding affinity through conformational constraint and potentially establish more favorable interactions within the JNK3 binding pocket while maintaining the core structure and linker.\",\n    \"Final_Target_Molecule\": \"C1CC1C(=O)NC(C)c1ccc(OC2CCN(c3ccnc(N4CCCC(F)(F)C4)n3)C2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CC(C)C(CO)Nc1nc(NCc2cccc(I)c2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a purine core (imidazo[4,5-d]pyrimidine). Key substituents include: an (S)-2-amino-3-methylbutan-1-ol group at position 2, a (3-iodobenzyl)amino group at position 6, and an isopropyl group at the N7 position of the imidazole ring.\",\n    \"Property_Analysis\": \"The purine scaffold is common in kinase inhibitors, mimicking ATP binding. The substituents modulate binding affinity and selectivity. The (3-iodobenzyl)amino group likely interacts with the hinge region or a hydrophobic pocket, with the iodine potentially contributing via hydrophobic interactions or halogen bonding. The amino alcohol at C2 may interact with the solvent-exposed region and influence solubility. The N7-isopropyl group occupies a specific pocket.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The large iodine atom at the meta-position of the benzyl ring might not be optimal for JNK3 inhibition compared to other halogens or functional groups. It increases lipophilicity significantly and could lead to potential metabolic liabilities or off-target effects. Potency or selectivity might be improved by modifying this position.\",\n    \"Optimization_for_Source_Molecule\": \"Replace the iodine atom on the benzyl ring with a chlorine atom. Chlorine is smaller, less lipophilic than iodine, and can still participate in favorable interactions (hydrophobic/halogen bonding) within the binding site, potentially improving potency, selectivity, or pharmacokinetic properties relevant to JNK3 inhibition.\",\n    \"Final_Target_Molecule\": \"CC(C)C(CO)Nc1nc(NCc2cccc(Cl)c2)c2ncn(C(C)C)c2n1\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(C=CC(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a central pyridine ring connected via an amide linkage to a vinylogous acrylamide system, which terminates in a 4-methoxyphenyl group. The pyridine core is also substituted with a complex 1,2,4-triazole heterocycle. This triazole ring bears three substituents: a methyl group, a methylthio (SC) group, and a 4-fluorophenyl group. The overall structure resembles typical ATP-competitive kinase inhibitors with potential hinge-binding elements (pyridine, triazole) and groups occupying hydrophobic pockets (fluorophenyl, methoxyphenyl).\",\n    \"Property_Analysis\": \"The pyridine and triazole nitrogen atoms are potential hydrogen bond acceptors for interacting with the kinase hinge region (e.g., Met residue in JNK3). The 4-fluorophenyl group likely occupies a hydrophobic pocket near the ATP binding site. The extended conjugated system involving the acrylamide and methoxyphenyl group projects towards the solvent-exposed region or potentially another sub-pocket. The methylthio group contributes to the electronic properties and steric profile of the triazole core.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylthio (SC) group on the triazole is a potential site for metabolic oxidation (S-oxidation), potentially leading to poor pharmacokinetic properties or altered activity. Its contribution to binding affinity might not be optimal compared to alternative substituents that could offer stronger interactions, such as hydrogen bonding. The flexibility of the vinylogous acrylamide linker might also lead to an entropic penalty upon binding. The overall potency and selectivity for JNK3 over other kinases might need improvement.\",\n    \"Optimization_for_Source_Molecule\": \"To address the potential metabolic liability and potentially improve binding affinity through hydrogen bonding, the methylthio (SC) group on the triazole ring will be replaced with an amino (NH2) group. The amino group is less prone to the specific oxidation pathway of the thioether and can act as a hydrogen bond donor, potentially forming favorable interactions within the JNK3 active site.\",\n    \"Final_Target_Molecule\": \"COc1ccc(C=CC(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc(N)n3C)ccn2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "COC1CCCN(c2nccc(N3CCC(Oc4ccc(C(C)NC(C)=O)cc4)C3)n2)C1",
        "prop": "jnk",
        "json_results": "[{\n  \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, COC1CCCN(c2nccc(N3CCC(Oc4ccc(C(C)NC(C)=O)cc4)C3)n2)C1, comprises a central aminopyrimidine core. This core is substituted at one amino position with a 3-methoxy-pyrrolidine ring and at the C4 position with a piperidine ring. The piperidine acts as a linker to a phenoxy group, which is further substituted at the para position with an N-acetyl-1-aminoethyl group (C(C)NC(C)=O). Key functional groups include the pyrimidine nitrogens, ether oxygens, piperidine nitrogen, and the terminal amide group, offering potential hydrogen bonding sites and hydrophobic interactions.\",\n  \"Property_Analysis\": \"The aminopyrimidine core is a well-established scaffold for kinase inhibitors, suggesting the source molecule likely exhibits inhibitory activity against kinases, potentially including JNK3. The molecule's architecture allows for interactions typical of ATP-competitive inhibitors: the pyrimidine likely interacts with the kinase hinge region, while the substituted phenoxy group extends into a hydrophobic pocket. The methoxy-pyrrolidine likely occupies the solvent-exposed region.\",\n  \"Limitation_in_Source_Molecule_for_Property\": \"The N-acetyl-1-aminoethyl substituent [C(C)NC(C)=O] on the phenoxy ring might represent a limitation. The terminal amide group could be susceptible to hydrolysis, reducing metabolic stability. Furthermore, the size, flexibility, and polarity of this group might not be optimal for achieving high potency and selectivity for the JNK3 active site, potentially leading to weaker binding affinity compared to alternative substituents designed for specific hydrophobic or polar interactions within the target pocket.\",\n  \"Optimization_for_Source_Molecule\": \"To potentially enhance JNK3 inhibition, metabolic stability, and binding affinity, the N-acetyl-1-aminoethyl group [C(C)NC(C)=O] at the para position of the phenoxy ring will be replaced. A common optimization strategy involves substituting such groups with smaller, metabolically stable, electron-withdrawing groups that can improve interactions within hydrophobic pockets. Therefore, this group will be replaced with a trifluoromethyl (CF3) group, known for its metabolic stability and ability to enhance binding affinity through favorable hydrophobic and electronic contributions.\",\n  \"Final_Target_Molecule\": \"COC1CCCN(c2nccc(N3CCC(Oc4ccc(C(F)(F)F)cc4)C3)n2)C1\"\n}]"
    },
    {
        "src_smiles": "COc1cc2ncnc(N3CCN(C(=O)NCc4ccc(Br)cc4)CC3)c2cc1OC",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a 6,7-dimethoxyquinazoline core, which is a common scaffold in kinase inhibitors, likely interacting with the ATP hinge region. This core is linked via position 4 to a piperazine ring. The piperazine nitrogen is further functionalized with an N-(4-bromobenzyl)acetamide group.\",\n    \"Property_Analysis\": \"The quinazoline core provides the primary anchor to the kinase hinge. The dimethoxy groups potentially influence solubility and metabolic stability, while also modulating electronic properties. The piperazine acts as a flexible linker, positioning the bromobenzylamide moiety towards the solvent-exposed region or potentially a specific sub-pocket. The bromobenzyl group contributes to hydrophobic interactions, and the amide group can act as both H-bond donor and acceptor.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The 4-bromobenzyl group might not be optimal for JNK3 inhibition. While providing lipophilicity, the bromine atom's size and electronic properties may not perfectly fit the target sub-pocket, potentially limiting potency or selectivity. Alternative substituents could offer improved hydrophobic interactions, hydrogen bonding, or better packing efficiency.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition, the 4-bromobenzyl moiety will be modified. The bromine atom will be replaced with a trifluoromethyl (CF3) group. The CF3 group is strongly electron-withdrawing and lipophilic, often improving metabolic stability and potency by engaging in specific hydrophobic or orthogonal multipolar interactions within kinase binding sites. This modification aims to improve the interaction profile within the relevant JNK3 sub-pocket.\",\n    \"Final_Target_Molecule\": \"COc1cc2ncnc(N3CCN(C(=O)NCc4ccc(C(F)(F)F)cc4)CC3)c2cc1OC\"\n  }\n]"
    },
    {
        "src_smiles": "COc1ccc(NC(=O)Nc2ccc(N(C)c3ncnc4cc(OC)c(OC)cc34)cc2)cc1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The molecule features a 4-(N-methylanilino)-6,7-dimethoxyquinazoline core, recognized as a kinase inhibitor scaffold, connected through a urea linker (-NHC(=O)NH-) to a terminal p-methoxyphenyl group.\",\n    \"Property_Analysis\": \"The 4-anilinoquinazoline fragment likely targets the ATP-binding pocket of JNK3, potentially forming hydrogen bonds with the hinge region via quinazoline nitrogens. The N-methylaniline, urea linker, and terminal methoxyphenyl group occupy different subpockets, influencing binding affinity, selectivity profile against other kinases, and pharmacokinetic properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The terminal p-methoxyphenyl group might not be optimal for specific interactions within the JNK3 binding site compared to substituents often found in selective JNK3 inhibitors. The urea linker can sometimes lead to suboptimal pharmacokinetic properties like poor solubility or metabolic instability. The quinazoline core itself, while a potent kinase binder, is common in inhibitors of other kinases (e.g., EGFR), potentially limiting JNK3 selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition and potentially improve properties, the terminal p-methoxyphenyl group is replaced with a 4-pyridyl moiety. The pyridine ring introduces a nitrogen atom capable of acting as a hydrogen bond acceptor, potentially forming favorable interactions in the solvent-exposed region of the JNK3 active site and potentially improving solubility compared to the methoxyphenyl group, while retaining the established quinazoline core and urea linker.\",\n    \"Final_Target_Molecule\": \"O=C(Nc1ccc(N(C)c2ncnc3cc(OC)c(OC)cc23)cc1)Nc4ccncc4\"\n  }\n]"
    },
    {
        "src_smiles": "CSc1nc(N)cc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a central aminopyrimidine core, a known hinge-binding motif in kinase inhibitors. It is substituted at one position with a methylthio (CS) group and at another position with a complex pyrazole moiety. This pyrazole ring is further substituted with a 4-fluorophenyl group and a propyl-morpholine chain.\",\n    \"Property_Analysis\": \"The aminopyrimidine core likely interacts with the hinge region of JNK3. The 4-fluorophenyl group can occupy a hydrophobic pocket, potentially forming favorable interactions. The propyl-morpholine chain extends towards the solvent-exposed region, potentially improving solubility and metabolic stability, and might form additional interactions depending on the specific topology of the JNK3 binding site.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The methylthio (CS) group is a potential metabolic liability (S-oxidation) and might not be optimal for potency or selectivity compared to other small hydrophobic groups. Its size and electronic properties might not provide the best fit or interaction profile within the corresponding kinase subpocket.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve metabolic stability and potency, the methylthio (CS) group will be replaced with a cyclopropyl group. Cyclopropyl groups are often used to replace metabolically labile groups or to fill small hydrophobic pockets effectively, potentially enhancing binding affinity while maintaining or improving metabolic profile.\",\n    \"Final_Target_Molecule\": \"Nc1nc(C2CC2)cc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CCOC(=O)Nc1ncc(Oc2cc(I)c(OC)cc2C(C)C)c(N)n1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule, CCOC(=O)Nc1ncc(Oc2cc(I)c(OC)cc2C(C)C)c(N)n1, features a 2,4-diaminopyrimidine core. One amino group is unsubstituted (at C4), while the other (at C2) bears an ethyl carbamate substituent. The pyrimidine ring is further substituted at C5 with a phenoxy group. This phenyl ring is substituted with iodine, methoxy, and isopropyl groups.\",\n    \"Property_Analysis\": \"The aminopyrimidine core is a known hinge-binding motif for kinases like JNK3. The C4 amino group likely forms crucial hydrogen bonds with the kinase hinge region. The substituted phenoxy group occupies the hydrophobic pocket near the ATP binding site, with the substituents (I, OMe, iPr) modulating potency and selectivity. The ethyl carbamate group projects towards the solvent-exposed region or ribose pocket and influences physicochemical properties.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The ethyl carbamate group (N-COOEt) might be suboptimal for binding interactions and potentially metabolically labile due to ester hydrolysis, limiting bioavailability or duration of action. The large iodine atom, while potentially contributing to potency via halogen bonding, might negatively impact ADME properties (e.g., metabolic stability, off-target interactions). The overall combination of substituents might not be fully optimized for maximal JNK3 potency and selectivity.\",\n    \"Optimization_for_Source_Molecule\": \"To enhance JNK3 inhibition and improve drug-like properties: 1. Replace the ethyl carbamate group (CCOC(=O)N-) with a more stable and potentially better interacting group, such as an acetylamino group (CC(=O)N-). This retains hydrogen bonding potential while removing the labile ester. 2. Replace the iodine atom on the phenyl ring with a chlorine atom. Chlorine can still participate in halogen bonding interactions but often leads to improved pharmacokinetic properties compared to iodine.\",\n    \"Final_Target_Molecule\": \"CC(=O)Nc1ncc(Oc2cc(Cl)c(OC)cc2C(C)C)c(N)n1\"\n  }\n]"
    },
    {
        "src_smiles": "CCCONC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a benzimidazole core substituted with a (E)-2-(pyridin-2-yl)vinyl group at the 2-position. A phenyl ring is attached to the benzimidazole core via a thioether linkage. This phenyl ring is further substituted with an N-propoxybenzamide group (`CCCONC(=O)-`). Key moieties include: Benzimidazole, Styrylpyridine, Thioether linker, N-propoxybenzamide.\",\n    \"Property_Analysis\": \"Benzimidazole derivatives are common scaffolds for kinase inhibitors, including JNK inhibitors. The styrylpyridine group likely interacts with the hinge region or adjacent hydrophobic pockets of JNK3. The N-propoxybenzamide thioether portion occupies another region, potentially the solvent-exposed area or a specific subpocket, influencing overall binding affinity and properties like solubility and metabolic stability.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The N-propoxyamide group (`-CON(OCCC)`) contains a potentially labile N-O bond, which might lead to metabolic instability or undesired reactivity. The thioether linkage (`-S-`) is susceptible to oxidation (to sulfoxide and sulfone), potentially altering binding affinity and pharmacokinetic properties. The overall combination of these groups might not be optimal for potent and selective JNK3 inhibition or possess ideal drug-like properties.\",\n    \"Optimization_for_Source_Molecule\": \"To improve stability and potentially enhance JNK3 binding affinity, the optimization strategy focuses on replacing the labile N-propoxybenzamide and thioether moieties. Replace the entire `CCCONC(=O)c1ccccc1S-` fragment with a more stable and commonly used group in kinase inhibitors, connected via a robust amine (`-NH-`) linker. A 4-fluoroaniline group (`Fc1ccc(N)cc1`) is chosen, replacing the thioether with an amine linker and the complex N-propoxybenzamide phenyl part with a simple 4-fluorophenyl group. This modification aims to improve metabolic stability and potentially optimize interactions within the JNK3 binding site.\",\n    \"Final_Target_Molecule\": \"Fc1ccc(Nc2ccc3c(n[nH]c3C=Cc3ccccn3)c2)cc1\"\n  }\n]"
    },
    {
        "src_smiles": "CCOC(=O)CN1C(=O)SC(=Cc2ccc(-c3ccc(Cl)cc3Cl)o2)C1=O",
        "prop": "jnk",
        "json_results": "[\n  {\n    \"Structural_Analysis_of_Source_Molecule\": \"The source molecule features a rhodanine-like thiazolidinedione core (specifically, a 2,4-thiazolidinedione). An ethyl carboxymethyl group (-CH2COOEt) is attached to the nitrogen atom (N1). An exocyclic double bond at C5 connects the core to a furan ring. The furan ring is substituted at its 5-position with a 3,4-dichlorophenyl group.\",\n    \"Property_Analysis\": \"Rhodanine derivatives are known inhibitors of various kinases, including JNKs. The activity often relies on interactions within the ATP-binding site. The thiazolidinedione core can form hydrogen bonds (e.g., with the hinge region), while the aryl moiety (dichlorophenyl-furan) typically occupies a hydrophobic pocket. The N-substituent can influence solubility, cell permeability, and interactions with solvent-exposed regions or adjacent pockets.\",\n    \"Limitation_in_Source_Molecule_for_Property\": \"The ethyl ester group (-COOEt) on the N-substituent might not be optimal for JNK3 inhibition. Esters can be metabolically labile (hydrolysis). Furthermore, this group might not provide specific favorable interactions (like hydrogen bonding) that could enhance binding affinity compared to other substituents like a carboxylic acid or amide.\",\n    \"Optimization_for_Source_Molecule\": \"To potentially improve JNK3 inhibition and metabolic stability, the ethyl ester group will be hydrolyzed to the corresponding carboxylic acid. The carboxylic acid (-COOH) can act as both a hydrogen bond donor and acceptor, potentially forming stronger interactions with the target protein compared to the ester. This modification maintains the core scaffold and the key hydrophobic interaction group while altering the N-substituent's properties.\",\n    \"Final_Target_Molecule\": \"O=C(O)CN1C(=O)SC(=Cc2ccc(-c3ccc(Cl)cc3Cl)o2)C1=O\"\n  }\n]"
    }
]